Modern methods of echocardiographic assessment of the functional status of the left atrium in atrial fibrillation ; Современные методы эхокардиографической оценки функционального состояния левого предсердия при фибрилляции предсердий

Authors: M. Kadirova, E. V. Yalova, F. S. Shebzuhova, A. A. Botasheva, E. D. Strebkova, G. G. Kаrmаzаnovsky, A. Sh. Revishvili, М. Кадырова, Е. В. Ялова, Ф. С. Шебзухова, А. А. Боташева, Е. Д. Стребкова, Г. Г. Кармазановский, А. Ш. Ревишвили

Source: Medical Visualization; Том 27, № 3 (2023); 24-40 ; Медицинская визуализация; Том 27, № 3 (2023); 24-40 ; 2408-9516 ; 1607-0763

Subject Terms: спекл-трекинг-эхокардиография, left atrium, speckle tracking echocardiography, левое предсердие

File Description: application/pdf

Relation: https://medvis.vidar.ru/jour/article/view/1398/837; Chao T.F., Liu C.J., Tuan T.C. et al. Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation: A Report From the Taiwan Nationwide AF Cohort Study. Chest. 2018; 153: 453–466. https://doi.org/10.1016/j.chest.2017.10.001; Шапкина М.Ю., Маздорова Е.В., Авдеева Е.М., Щербакова Л.В., Рябиков А.Н., Hubacek J., Bobak M., Малютина С.К. Динамика частоты фибрилляции предсердий в российской популяционной выборке за 13 лет наблюдения. Кардиоваскулярная терапия и профилактика. 2022; 21 (8): 3108. https://doi.org/10.15829/1728-8800-2022-3108; Brundel B.J.J.M., Ai X., Hills M.T. et al. Atrial fibrillation. Nat. Rev. Dis. Primers. 2022; 8 (1): 21. https://doi.org/10.1038/s41572-022-00347-9; Benjamin E.J., Muntner P., Alonso A. et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report from the American Heart Association. Circulation. 2019; 139: 56–528. https://doi.org/10.1161/CIR.0000000000000659; Гурина В.И., Кондратьев Е.В., Кармазановский Г.Г., Хацаюк Е.А. МСКТ-волюметрия левого предсердия у пациентов кардиологического профиля. Медицинская визуализация. 2017; 6: 13–18. https://doi.org/10.24835/1607-0763-2017-6-13-18; Павлюкова Е.Н., Кужель Д.А., Матюшин Г.В. Функция левого предсердия: современные методы оценки и клиническое значение. Рациональная фармакотерапия в кардиологии. 2017; 13 (5): 675–683. https://doi.org/10.20996/1819-6446-2017-13-5-675-683; Хажбиева С.М., Темботова Ж.Х., Сергуладзе С.Ю., Проничева И.В., Кваша Б.И., Ханкишиева Ф.Р., Мустапаева З.В. Оценка параметров геометрического, функционального и механического ремоделирования левого предсердия после хирургического лечения изолированной фибрилляции предсердий. Анналы аритмологии. 2018; 15 (1): 12–23. https://doi.org/10.15275/annaritmol.2018.1.2; Ревишвили А.Ш., Макаренко В.Н., Александрова С.А. Оценка морфологии легочных вен у пациентов c фибрилляцией предсердий c использованием компьютерной ангиографии. Вестник аритмологии. 2006; 45: 42–47.; Kislitsina O.N., Revishvili A.S., Cox J.L. Unlocking the secrets to regenerating cardiac tissue: an update. Interact Cardiovasc. Thorac. Surg. 2018; 26 (1): 146–153. https://doi.org/10.1093/icvts/ivx264; Ревишвили А.Ш., Кадырова М., Попов В.А., Малышенко Е.С., Кармазановский Г.Г., Стребкова Е.Д., Широков В.С., Новиков М.А., Ялова Е.В., Таймасова И.А. Влияние индексируемого объема левого предсердия на эффективность торакоскопического лечения фибрилляции предсердий. Медицинская визуализация. 2022; 26 (3): 22–33. https://doi.org/10.24835/1607-0763-1162; Апарина О.П., Стукалова О.В., Пархоменко Д.В., Миронова Н.А., Буторова Е.А., Болотова М.Н., Макеев М.И., Терновой С.К., Голицын С.П. Характеристика структуры миокарда левого предсердия у больных мерцательной аритмией и здоровых лиц по данным магнитно-резонансной томографии с отсроченным контрастированием. Вестник аритмологии. 2014; 77: 5–12.; Delgado V., Di Biase L., Leung M. et al. Structure and Function of the Left Atrium and Left Atrial Appendage: AF and Stroke Implications. J. Am. Coll. Cardiol. 2017; 70: 3157–3172. https://doi.org/10.1016/j.jacc.2017.10.063; Никифоров В.С., Никищенкова Ю.В. Современные возможности speckle tracking эхокардиографиии в клинической практике. Рациональная фармакотерапия в кардиологии. 2017; 13 (2): 248–255. https://doi.org/10.20996/1819-6446-2017-13-2-248-255; Сморгон А.В., Лебедев Д.И., Усенков С.Ю., Дубанаев А.А., Арчаков Е.А., Баталов Р.Е., Шелемехов А.Е., Попов С.В. Применение speckletracking внутрисердечной эхокардиографии у пациентов с фибрилляцией предсердий во время радиочастотной изоляции легочных вен. Российский кардиологический журнал. 2017; 7: 117–120. http://dx.doi.org/10.15829/1560-4071-2017-7-117-120; Мусин Т.И., Багманова З.А., Гареев Д.А., Руденко В.Г., Загидуллин Н.Ш. Прогнозирование контроля синусового ритма после радиочастотной аблации у больных с фибрилляцией предсердий с помощью технологии спекл-трекинг и динамика структурно-функциональных показателей левого предсердия. Российский кардиологический журнал. 2021; 26 (2S): 42–56. https://doi.org/10.15829/1560-4071-2021-4256; Kislitsina O.N., Cox J.L., Shah S.J. et al. Preoperative left atrial strain abnormalities are associated with the development of postoperative atrial fibrillation following isolated coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 2022; 164 (3): 917–924. https://doi.org/10.1016/j.jtcvs.2020.09.130; Mandoli G.E., Borrelli C., Cameli M. et al. Speckle tracking echocardiography in heart failure development and progression in patients with apneas. Heart Fail. Rev. 2022; 27 (5):1869–1881. https://doi.org/10.1007/s10741-021-10197-4; Hassanin M., Ong G., Connelly K.A. Right Ventricle Longitudinal Strain: A New Tool in Functional Tricuspid Regurgitation Prognostication. Can. J. Cardiol. 2021; 37: 945–948. https://doi.org/10.1016/j.cjca.2021.04.001; Ferkh A., Clark A., Thomas L. Left atrial phasic function: physiology, clinical assessment and prognostic value. Heart. 2023: heartjnl-2022-321609. https://doi.org/10.1136/heartjnl-2022-321609; Badano L.P., Kolias T.J., Muraru D. et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ ASE/Industry Task Force to standardize deformation imaging. Eur. Heart. J. Cardiovasc. Imaging. 2018; 19: 591–600. https://doi.org/10.1093/ehjci/jey042; Pathan F., D'Elia N., Nolan M.T.et al. Normal Ranges of Left Atrial Strain by Speckle-Tracking Echocardiography: A Systematic Review and Meta-Analysis. J. Am. Soc. Echocardiogr. 2017; 30 (1): 59–70.e8. https://doi.org/10.1016/j.echo.2016.09.007; Кадырова М.В., Ревишвили А.Ш., Стребкова Е.Д., Широков В.С., Ялова Е.В., Кармазановский Г.Г. Лучевые методы оценки функции левого предсердия при фибрилляции предсердий (Обзор литературы). Журнал Диагностическая и интервенционная радиология. 2022; 16 (4); 46–60. https://doi.org/10.25512/DIR.2022.16.4.05; Cameli M., Lisi M., Righini F.M. et al. Novel echocardiographic techniques to assess left atrial size, anatomy and function. Cardiovasc. Ultrasound. 2012; 10: 4. https://doi.org/10.1186/1476-7120-10-4; Mouselimis D., Tsarouchas A.S., Pagourelias E.D. et al. Left atrial strain, intervendor variability, and atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis. Hellenic J. Cardiol. 2020; 61 (3): 154–164. https://doi.org/10.1016/j.hjc.2020.04.008; Donal E., Lip G.Y.H., Galderisi M. et al. EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J. Cardiovasc. Imaging. 2016; 17 (4): 355–383. https://doi.org/10.1093/ehjci/jev354; Gan G.C.H., Ferkh A., Boyd A., Thomas L. Left atrial function: evaluation by strain analysis. Cardiovasc. Diagn. Ther. 2018; 8 (1): 29–46. https://doi.org/10.21037/cdt.2017.06.08; Cameli M., Caputo M., Mondillo S. et al. Feasibility and reference values of left atrial longitudinal strain imaging by two dimensional speckle tracking. Cardiovasc. Ultrasound. 2009; 7: 6. https://doi.org/10.1186/1476-7120-7-6; Yasuda R., Murata M., Roberts R. et al. Left atrial strain is a powerful predictor of atrial fibrillation recurrence after catheter ablation: study of a heterogeneous population with sinus rhythm or atrial fibrillation. Eur. Heart J. Cardiovasc. Imaging. 2015; 16 (9): 1008–1014. https://doi.org/10.1093/ehjci/jev028; Saraiva R.M., Demirkol S., Buakhamsri A. et al. Left atrial strain measured by two-dimensional speckle tracking represents a new tool to evaluate left atrial function. J. Am. Soc. Echocardiogr. 2010; 23 (2): 172–180. https://doi.org/10.1016/j.echo.2009.11.003; Yang C.H., Liu H.T., Lee H.L., Lin F.C., Chou C.C. Left atrial booster-pump function as a predictive parameter for atrial fibrillation in patients with severely dilated left atrium. Quant Imaging Med Surg. 2022; 12 (4): 2523– 2534. https://doi.org/10.21037/qims-21-954; Rimbaş R.C., Dulgheru R.E., Vinereanu D. Methodological Gaps in Left Atrial Function Assessment by 2D Speckle Tracking Echocardiography. Arq. Bras. Cardiol. 2015; 105 (6): 625–636. https://doi.org/10.5935/abc.20150144; Atas H., Kepez A., Tigen K. et al. Evaluation of left atrial volume and function in systemic sclerosis patients using speckle tracking and real-time three-dimensional echocardiography. Anatol. J. Cardiol. 2016; 16: 316–322. https://doi.org/10.5152/anatoljcardiol.2015.6268; Kim K.J., Choi H.M., Yoon Y.E. et al. Left atrial mechanical function and global strain in hypertrophic cardiomyopathy. PLoS One. 2016; 11: e0157433. https://doi.org/10.1371/journal.pone.0157433; Singh A., Carvalho Singulane C., Miyoshi T. et al. WASE Investigators. Normal Values of Left Atrial Size and Function and the Impact of Age: Results of the World Alliance Societies of Echocardiography Study. J. Am. Soc. Echocardiogr. 2022; 35 (2): 154–164.e3. https://doi.org/10.1016/j.echo.2021.08.008; Morris D.A., Takeuchi M., Krisper M. et al. Normal values and clinical relevance of left atrial myocardial function analysed by speckle-tracking echocardiography: multicentre study. Eur. Heart J. Cardiovasc. Imaging. 2015; 16 (4): 364–372. https://doi.org/10.1093/ehjci/jeu219; Sun B.J., Park J.H., Lee M. et al. Normal reference values for left atrial strain and its determinants from a large Korean multicenter registry. J. Cardiovasc. Imaging. 2020; 28: 186–198. https://doi.org/10.1111/j.1540-8159.2010.02841.x; Liao J.N., Chao T.F., Kuo J.Y. et al. Age, sex, and blood pressurerelated infuences on reference values of left atrial deformation and mechanics from a large-scale Asian population. Circ. Cardiovasc. Imaging. 2017; 10: e006077 https://doi.org/10.1161/CIRCIMAGING.116.006077; Sugimoto T., Robinet S., Dulgheru R. et al. Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study. Eur. Heart J. Cardiovasc. Imaging. 2018; 19: 630–638. https://doi.org/10.1093/ehjci/jey018; van Grootel R.W.J., Strachinaru M., Menting M.E. et al. In-depth echocardiographic analysis of left atrial function in healthy adults using speckle tracking echocardiography and volumetric analysis. Echocardiography. 2018; 35: 1956–1965. https://doi.org/10.1111/echo.14174; Thomas L., Muraru D., Popescu B.A. et al. Evaluation of Left Atrial Size and Function: Relevance for Clinical Practice. J. Am. Soc. Echocardiogr. 2020; 33 (8): 934– 952. https://doi.org/10.1016/j.echo.2020.03.021; Mălăescu G.G., Mirea O., Capotă R. et al. Left Atrial Strain Determinants During the Cardiac Phases. JACC Cardiovasc Imaging. 2022; 15 (3): 381–391. https://doi.org/10.1016/j.jcmg.2021.09.009; Gan G.C.H., Bhat A., Chen H.H.L. et al. Determinants of LA reservoir strain: Independent effects of LA volume and LV global longitudinal strain. Echocardiography. 2020; 37 (12): 2018–2028. https://doi.org/10.1111/echo.14922; Bao L., Cheng L., Gao X. et al. Left atrial morphofunctional remodeling in atrial fibrillation assessed by three-dimensional speckle tracking echocardiography and its value in atrial fibrillation screening. Cardiovasc. Ultrasound. 2022; 20 (1): 13. https://doi.org/10.1186/s12947-022-00282-5; Mochizuki A., Yuda S., Oi Y. et al. Assessment of left atrial deformation and synchrony by three-dimensional speckletracking echocardiography: comparative studies in healthy subjects and patients with atrial fibrillation. J. Am. Soc. Echocardiogr. 2013; 26 (2): 165–174. https://doi.org/10.1016/j.echo.2012.10.003; Olsen F.J., Bertelsen L., de Knegt M.C. et al. Multimodality cardiac imaging for the assessment of left atrial function and the Association with atrial arrhythmias. Circ. Cardiovasc. Imaging. 2016; 9 (10). https://doi.org/10.1161/CIRCIMAGING.116.004947; Gupta D.K., Shah A.M., Giugliano R.P. et al. Left atrial structure and function in atrial fibrillation: ENGAGE AFTIMI 48. Eur. Heart J. 2014; 35 (22): 1457–1465. https://doi.org/10.1093/eurheartj/eht500; Shin S.Y., Lim H.E., Choi U.J. et al. Impaired transport function of the left atrium in patients with lone paroxysmal atrial fibrillation. Echocardiography. 2011; 28 (1): 44–51. https://doi.org/10.1111/j.1540-8175.2010.01271.x; Shang Z., Su D., Cong T. et al. Assessment of left atrial mechanical function and synchrony in paroxysmal atrial fibrillation with two-dimensional speckle tracking echocardiography. Echocardiography. 2017; 34 (2): 176–183. https://doi.org/10.1111/echo.13434; Mochizuki A., Yuda S., Oi Y. et al. Assessment of left atrial deformation and synchrony by three-dimensional speckle-tracking echocardiography: comparative studies in healthy subjects and patients with atrial fibrillation. J. Am. Soc. Echocardiogr. 2013; 26 (2): 165–174. https://doi.org/10.1016/j.echo.2012.10.003; Chadaide S., Domsik P., Kalapos A., et al. Threedimensional speckle tracking echocardiography-derived left atrial strain parameters are reduced in patients with atrial fibrillation (results from the MAGYAR-path study). Echocardiography. 2013; 30 (9): 1078–1083. https://doi.org/10.1111/echo.12218; Atsuko F., Katsuhisa I., Eiichi H. et al. Three-dimensional speckle tracking imaging for assessing left atrial function in hypertensive patients with paroxysmal atrial fibrillation. Int. Heart J. 2016; 57 (6): 705. https://doi.org/10.1536/ihj.16-121.; Hindricks G., Potpara T., Dagres N. et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2020; 42 (5): 373–498. https://doi.org/10.1093/eurheartj/ehaa612; Benjamin E.J., Muntner P., Alonso A. et al. Heart disease and stroke statistics – 2019 update: a report from the American Heart Association. Circulation. 2019; 139 (10): e56–e528. https://doi.org/10.1161/CIR.0000000000000659; Reiffel J.A., Verma A., Kowey P.R. et al. Incidence of previously undiagnosed atrial fibrillation using Insertable cardiac monitors in a high-risk population: the REVEAL AF study. JAMA Cardiol. 2017; 2 (10): 1120–1127. https://doi.org/10.1001/jamacardio.2017.3180; Brachmann J., Morillo C.A., Sanna T. et al. Uncovering atrial fibrillation beyond short-term monitoring in cryptogenic stroke patients: three-year results from the cryptogenic stroke and underlying atrial fibrillation trial. Circ. Arrhythm. Electrophysiol. 2016; 9 (1): e003333. https://doi.org/10.1161/circep.115.003333; Casaclang-Verzosa G., Gersh B.J., Tsang T.S. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J. Am. Coll. Cardiol. 2008; 51: 1–11. https://doi.org/10.4022/jafib.986; Hoit B.D. Left atrial size and function: role in prognosis. J. Am. Coll. Cardiol. 2014; 63: 493–505. https://doi.org/10.1016/j.jacc.2013.10.055; Yuda S., Muranaka A., Miura T. Clinical implications of left atrial function assessed by speckle tracking echocardiography. J Echocardiogr. 2016; 14: 104–112. https://doi.org/10.1016/j.jacc.2013.10.055; Kojima T., Kawasaki M., Tanaka R. et al. Left atrial global and regional function in patients with paroxysmal atrial fibrillation has already been impaired before enlargement of left atrium: velocity vector imaging echocardiography study. Eur. Heart J. Cardiovasc. Imaging. 2012; 13: 227–234. https://doi.org/10.1093/ejechocard/jer281; Yoon Y.E., Oh I.Y., Kim S.A. et al. Echocardiographic Predictors of Progression to Persistent or Permanent Atrial Fibrillation in Patients with Paroxysmal Atrial Fibrillation (E6P Study). J. Am. Soc. Echocardiogr. 2015; 28: 709–717. https://doi.org/10.1016/j.echo.2015.01.017; Pagola J., González-Alujas T., Flores A. et al. Left atria strain is a surrogate marker for detection of atrial fibrillation in cryptogenic strokes. Stroke. 2014; 45: e164–166. https://doi.org/10.1161/STROKEAHA.114.005540; Tzou W.S., Marchlinski F.E., Zado E.S. et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ. Arrhythm. Electrophysiol. 2010; 3: 237–242. https://doi.org/10.1161/CIRCEP.109.923771; Oral H., Knight B.P., Tada H. et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 2002; 105: 1077–1081. https://doi.org/10.1038/s41569-020-00451-x; Berruezo A., Tamborero D., Mont L. et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur. Heart J. 2007; 28: 836–841. https://doi.org/10.1093/eurheartj/ehm027; Yasuda R., Murata M., Roberts R. et al. Left atrial strain is a powerful predictor of atrial fibrillation recurrence after catheter ablation: study of a heterogeneous population with sinus rhythm or atrial fibrillation. Eur. Heart J. Cardiovasc. Imaging. 2015; 16: 1008–1014. https://doi.org/10.1093/ehjci/jev028; Hammerstingl C., Schwekendiek M., Momcilovic D. et al. Left atrial deformation imaging with ultrasound based twodimensional speckle-tracking predicts the rate of recurrence of paroxysmal and persistent atrial fibrillation after successful ablation procedures. J. Cardiovasc. Electrophysiol. 2012; 23: 247–255. https://doi.org/10.1111/j.1540-8167.2011.02177.x; Schneider C., Malisius R., Krause K. et al. Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation. Eur. Heart J. 2008; 29 (11): 1397–1409. https://doi.org/10.1093/eurheartj/ehn168.; Kuppahally S.S., Akoum N., Burgon N.S. et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ. Cardiovasc. Imaging. 2010; 3 (3): 231–239. https://doi.org/10.1161/circimaging.109.865683; Ma X.X., Boldt L.H., Zhang Y.L. et al. Clinical relevance of left atrial strain to predict recurrence of atrial fibrillation after catheter ablation: a meta-analysis. Echocardiography. 2016; 33 (5): 724–733. https://doi.org/S1205380612X; Parwani A.S., Morris D.A., Blaschke F. et al. Left atrial strain predicts recurrence of atrial arrhythmias after catheter ablation of persistent atrial fibrillation. Open Heart. 2017; 4 (1): e000572. https://doi.org/10.1136/openhrt-2016-000572; Moreno-Ruiz L.A., Madrid-Miller A., Martinez-Flores J.E. et al. Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation. Int. J. Cardiovasc. Imaging. 2019; 35: 1587–1596. https://doi.org/10.1007/s10554-019-01597-7; Nielsen A.B., Skaarup K.G., Lassen M. et al. Usefulness of left atrial speckle tracking echocardiography in predicting recurrence of atrial fibrillation after radiofrequency ablation: a systematic review and meta-analysis. Int. J. Cardiovasc. Imaging. 2020; 36: 1293–1309. https://doi.org/10.1007/s10554-020-01828-2; Nielsen A.B., Skaarup K.G., Djernaes K. et al. Left atrial contractile strain predicts recurrence of atrial tachyarrhythmia after catheter ablation. Int. J. Cardiol. 2022; 358: 51–57. https://doi.org/10.1016/j.ijcard.2022.04.056; Nielsen A.B., Skaarup K.G., Hauser R. et al. Normal values and reference ranges for left atrial strain by speckletracking echocardiography: the Copenhagen City heart study. Eur. Heart J. Cardiovasc. Imaging. 2021; 23: 42–51. https://doi.org/10.1093/ehjci/jeab201; Obokata M., Negishi K., Kurosawa K. et al. Left atrial strain provides incremental value for embolism risk stratification over CHA2DS2-VASc score and indicates prognostic impact in patients with atrial fibrillation. J. Am. Soc. Echocardiogr. 2014; 27: 709–716.e4. https://doi.org/10.1016/j.echo.2014.03.010; Azemi T., Rabdiya V.M., Ayirala S.R. et al. Left atrial strain is reduced in patients with atrial fibrillation, stroke or TIA, and low risk CHADS(2) scores. J. Am. Soc. Echocardiogr. 2012; 25: 1327–1332. https://doi.org/10.1016/j.echo.2012.09.004; Shih J.Y., Tsai W.C., Huang Y.Y. et al. Association of decreased left atrial strain and strain rate with stroke in chronic atrial fibrillation. J. Am. Soc. Echocardiogr. 2011; 24: 513–519. https://doi.org/10.1016/j.echo.2011.01.016; Hsu P.C., Lee W.H., Chu C.Y. et al. Prognostic role of left atrial strain and its combination index with transmitral E-wave velocity in patients with atrial fibrillation. Sci. Rep. 2016; 6: 17318. https://doi.org/10.1038/srep17318; Olsen F.J., Jørgensen P.G., Møgelvang R. et al. Predicting Paroxysmal Atrial Fibrillation in Cerebrovascular Ischemia Using Tissue Doppler Imaging and Speckle Tracking Echocardiography J Stroke. J. Stroke Cerebrovasc. Dis. 2016; 25: 350–359. https://doi.org/10.1016/j.jstrokecere brovasdis.2015.10.004; Kim D., Shim C.Y., Cho I.J. et al. Incremental Value of Left Atrial Global Longitudinal Strain for Prediction of Post Stroke Atrial Fibrillation in Patients with Acute Ischemic Stroke. J. Cardiovasc. Ultrasound. 2016; 24: 20–27. https://doi.org/10.4250/jcu.2016.24.1.20.; https://medvis.vidar.ru/jour/article/view/1398

Availability: https://medvis.vidar.ru/jour/article/view/1398
https://doi.org/10.24835/1607-0763-1360

EVOLUTION OF THORACOSCOPIC TREATMENT OF ATRIAL FIBRILLATION: FROM INCEPTION TO CONTEMPORARY APPROACHES ; ЭВОЛЮЦИЯ ТОРАКОСКОПИЧЕСКОГО ЛЕЧЕНИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ: ОТ СТАНОВЛЕНИЯ ДО СОВРЕМЕННОГО ЭТАПА

Authors: Amiran S. Revishvili, Elena A. Artyukhina, Elizaveta D. Strebkova, Egor S. Malyshenko, Madina Kadyrova, Амиран Шотаевич Ревишвили, Елена Александровна Артюхина, Елизавета Дмитриевна Стребкова, Егор Сергеевич Малышенко, Мадина Кадырова

Contributors: Авторы заявляют об отсутствии финансирования статьи.

Source: Complex Issues of Cardiovascular Diseases; Том 12, № 2 (2023); 107-121 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 12, № 2 (2023); 107-121 ; 2587-9537 ; 2306-1278

Subject Terms: Левое предсердие, Atrial fibrillation, Left atrium, Фибрилляция предсердий

File Description: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/1335/796; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1331; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1332; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1333; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1334; https://www.nii-kpssz.com/jour/article/downloadSuppFile/1335/1335; Пиданов О.Ю., Богачев-Прокофьев А.В., Елесин Д.А., Иваницкий Э. А., Бобровский О. А., Шиленко П. А., Дурыгин П. А., Зотов А. С., Вачев С. А., Вайкин В. Е., Мамчур С. Е., Сапельников О. В., Быстров Д. О. Торакоскопическая аблация для лечения пациентов с изолированной формой фибрилляции предсердий в России. Патология кровообращения и кардиохирургия. 2018;22(2):14-21. doi:10.21688/1681-3472-2018-2-14-21.; Lippi G., Sanchis-Gomar F., Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217-221. doi:10.1177/1747493019897870.; Hindricks G., Potpara T., Dagres N., Arbelo Е., Bax J.J., Blomstrӧm-Lundqvist С., Boriani G., Castella M., Dan G., Dilaveris P.E., Fauchier L., Filippatos G., Kalman J.M., La Meir M., Lane D.A., Lebeau J., Lettino M., Lip G.Y., Pinto F.J., Neil Thomas G., Valgimigli M., Van Gelder I.C., Van Putte B.P., Watkins C.L.et al. Рекомендации ESC 2020 по диагностике и лечению пациентов с фибрилляцией предсердий, разработанные совместно с Европейской ассоциацией кардиоторакальной хирургии (EACTS). Российский кардиологический журнал. 2021;26(9):4701. doi:10.15829/1560-4071-2021-4701( doi:10.1093/eurheartj/ehaa945.); Haïssaguerre M., Jaïs P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Métayer P., Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–66. doi:10.1056/NEJM199809033391003.; Wesselink R., Neefs J., van den Berg N.W.E., Meulendijks E.R., Terpstra M.M., Kawasaki M., Nariswari F.A., Piersma F.R., van Boven W.J.P., Driessen A.H.G., de Groot J.R. Does left atrial epicardial conduction time reflect atrial fibrosis and the risk of atrial fibrillation recurrence after thoracoscopic ablation? Post hoc analysis of the AFACT trial. BMJ Open. 2022;12(3): 056829. doi:10.1136/bmjopen-2021-056829.; Артюхина Е.А., Дедух Е.В., Яшков М.В. Этапный хирургический и катетерный подход к лечению длительно-персистирующей фибрилляции предсердий. Российский кардиологический журнал. 2019;(7):96-98. doi:10.15829/1560-4071-2019-7-96-98.; Tilz R.R., Rillig A., Thum A.M., Arya A., Wohlmuth P., Metzner A., Mathew S., Yoshiga Y., Wissner E., Kuck K.H., Ouyang F. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg sequential ablation strategy. J Am Coll Cardiol. 2012;60:1921–9. doi:10.1016/j.jacc.2012.04.060.; Teunissen C., Kassenberg W., van der Heijden J.F., Hassink R.J., van Driel V.J., Zuithoff N.P., Doevendans P.A., Loh P. Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study. Europace. 2016;18:1335–42. doi:10.1093/europace/euv439.; Cox J.L. The longstanding, persistent confusion surrounding surgery for atrial fibrillation. J Thorac Cardiovasc Surg. 2010;139:1374–86. doi:10.1016/j.jtcvs.2010.02.027.; Lapenna E., De Bonis M., Giambuzzi I., Del Forno B., Ruggeri S., Cireddu M., Gulletta S., Castiglioni A., Alfieri O., Della Bella P., Benussi S. Long-term outcomes of stand-alone Maze IV for persistent or long-standing persistent atrial fibrillation. Ann Thorac Surg. 2020;109:124–31. doi:10.1093/icvts/ivab355.; Ad N., Holmes S.D., Friehling T. Minimally invasive stand-alone Cox Maze procedure for persistent and long-standing persistent atrial fibrillation: perioperative safety and 5-year outcomes. Circ Arrhythm Electrophysiol. 2017;10:e005352. doi:10.1161/CIRCEP.117.005352.; Haldar S., Khan H.R., Boyalla V., Kralj-Hans I., Jones S., Lord J., Onyimadu O., Satishkumar A., Bahrami T., De Souza A. et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J. 2020;41:4471–4480. doi:10.1093/eurheartj/ehaa658.; Ohtsuka T., Nonaka T., Hisagi M., Ninomiya M. En bloc left pulmonary vein and appendage isolation in thoracoscopic surgery for atrial fibrillation. Ann Thorac Surg. 2018;106:1340–7. doi:10.1016/j.athoracsur.2018.06.065.; van Laar C., Bentala M., Weimar T., Doll N., Swaans M.J., Molhoek S.G., Hofman F.N., Kelder J., van Putte B.P. Thoracoscopic ablation for the treatment of atrial fibrillation: a systematic outcome analysis of a multicentre cohort. Europace. 2019;21:893–9. doi:10.1093/europace/euy323.; Sindby J.E., Vadmann H., Lundbye-Christensen S., Riahi S., Hjortshøj S., Boersma L.V.A., Andreasen J.J. Percutaneous versus thoracoscopic ablation of symptomatic paroxysmal atrial fibrillation: a randomised controlled trial–the FAST II study. J Cardiothorac Surg. 2018;13(1): 101. doi:10.1186/s13019-018-0792-8.; Boersma L.V., Castella M., van Boven W., Berruezo A., Yilmaz A., Nadal M., Sandoval E., Calvo N., Brugada J., Kelder J., Wijffels M., Mont L. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125: 23-30. doi:10.1161/CIRCULATIONAHA.111.074047.; Saltman A.E., Rosenthal L.S., Francalancia N.A., Lahey S.J. A completely endoscopic approach to microwave ablation for atrial fibrillation. Heart Surg Forum. 2003;6:38–41.; Pruitt J.C., Lazzara R.R., Dworkin G.H. Badhwar V., Kuma C., Ebra G. Totally endoscopic ablation of lone atrial fibrillation: initial clinical experience. Ann Thorac Surg. 2006;81:1325-1330. doi:10.1016/j.athoracsur.2005.07.095.; Xu J., Luc J.G., Phan K. Atrial fibrillation: review of current treatment strategies. J Thorac Dis. 2016;8(9):886-900. doi:10.21037/jtd.2016.09.13.; Yilmaz A., Geuzebroek G.S., Van Putte B.P., Boersma L.V., Sonker U., De Bakker J.M., Van Boven W.J. Completely thoracoscopic pulmonary vein isolation with ganglionic plexus ablation and left atrial appendage amputation for treatment of atrial fibrillation. Eur J Cardiothorac Surg. 2010;38:356-60. doi:10.1016/j.ejcts.2010.01.058.; Pak H-N., Hwang C., Lim H.E., Kim J.S., Kim Y.H. Hybrid Epicardial and endocardial ablation of persistent or permanent atrial fibrillation: a new approach for difficult cases. J Cardiovasc Electrophysiol. 2007;18(9):917–23. doi:10.1111/j.1540-8167.2007.00882.x.; Mahapatra S., LaPar D.J., Kamath S., Payne J., Bilchick K.C., Mangrum J.M., Ailawadi G. Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and longstanding persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg. 2011;91(6):1890–8. doi:10.1016/j.athoracsur.2011.02.045.; Suárez A.G. Hornero F. Berjano E.J. Mathematical modeling of epicardial RF ablation of atrial tissue with overlying epicardial fat. Open Biomed Eng J. 2010; 4: 47-55. doi:10.2174/1874120701004020047.; Thomas S.P. Guy D.J. Boyd A.C., Eipper V.E., Ross D.L., Chard R.B. Comparison of epicardial and endocardial linear ablation using handheld probes. Ann Thorac Surg. 2003; 75: 543-548. doi:10.1016/s0003-4975(02)04314-x.; Gaynor S.L., Diodato M.D., Prasad S.M., Ishii Y., Schuessler R.B., Bailey M.S., Damiano N.R., Bloch J.B., Moon M.R., Damiano R.J. Jr. A prospective, single-center clinical trial of a modifi ed Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg. 2004;128:535-542. doi:10.1016/j.jtcvs.2004.02.044.; Accord R.E., van Suylen R.J., van Brakel T.J., Maessen J.G. Post-mortem histologic evaluation of microwave lesions after epicardial pulmonary vein isolation for atrial fi brillation. Ann Thorac Surg. 2005;80:881-7. doi:10.1016/j.athoracsur.2005.03.069.; Deneke T., Khargi K., Müller K.M., Lemke B., Mügge A., Laczkovics A., Becker A.E., Grewe P.H. Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. Eur Heart J. 2005;26:1797-803. doi:10.1093/eurheartj/ehi255.; Osmancik P., Budera P., Zdarska J., Herman D., Petr R., Straka Z. Electrophysiological findings after surgical thoracoscopic atrial fibrillation ablation. Heart Rhythm. 2016; 13: 1246-1252. doi:10.1016/j.hrthm.2016.02.007.; Pison L., La Meir M., van Opstal J., Blaauw Y., Maessen J., Crijns H.J. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2012;60(1):54–61. doi:10.1016/j.jacc.2011.12.055.; Kurfirst V., Mokraček A., Bulava A., Čanadyova J., Haniš J., Pešl L. Two-staged hybrid treatment of persistent atrial fibrillation: shortterm single-centre results. Interact Cardiovasc Thorac Surg. 2014;18(4):451–6. doi:10.1093/icvts/ivt538.; Wolf R.K., Schneeberger E.W., Osterday R., Miller D., Merrill W., Flege J.B. Jr., Gillinov A.M. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130:797-802. doi:10.1016/j.jtcvs.2005.03.041.; Gillinov A.M., Wolf R.K. Surgical ablation of atrial fibrillation. Prog Cardiovasc Dis. 2005;48(3):169-177. doi:10.1016/j.pcad.2005.06.012.; Beyer E., Lee R., Lam B.K. Point: Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation: early multicenter results. J Thorac Cardiovasc Surg. 2009;137(3): 521-526. doi:10.1016/j.jtcvs.2008.11.031.; Krul S.P.J., Driessen A.H.G., Zwinderman A.H., van Boven W.J., Wilde A.A., de Bakker J.M., de Groot J.R. Navigating the mini-maze: systematic review of the first results and progress of minimally-invasive surgery in the treatment of atrial fibrillation. Int J Cardiol 2013;166:132–40. doi:10.1016/j.ijcard.2011.10.011.; La Meir M., Gelsomino S., Lucà F., Pison L., Colella A., Lorusso R., Crudeli E., Gensini G.F., Crijns H.G., Maessen J. Minimal invasive surgery for atrial fibrillation: an updated review. Europace. 2013;15:170–82. doi:10.1093/europace/eus216.; Ревишвили А.Ш., Кадырова М., Стребкова Е.Д., Малышенко Е.С., Новиков М.А., Ялова Е.В., Бабаджанова К.А., Бондурко К.Э., Кармазановский Г.Г. Ампутация ушка левого предсердия с использованием эндостеплера при торакоскопической аблации фибрилляции предсердий. Комплексные проблемы сердечно-сосудистых заболеваний. 2023;12(1):58-71. doi:10.17802/2306-1278-2023-12-1-58-71.; van Laar C., Kelder J., van Putte B.P. The totally thoracoscopic maze procedure for the treatment of atrial fibrillation. Interact Cardiovasc Thorac Surg. 2017;24(1):102-111. doi:10.1093/icvts/ivw311.; Vos L.M., Kotecha D., Geuzebroek G.S.C., Hofman F.N., van Boven W.J.P., Kelder J., de Mol B.A.J.M., van Putte B.P.Totally thoracoscopic ablation for atrial fibrillation: a systematic safety analysis. Europace. 2018;20(11):1790-1797. doi:10.1093/europace/eux385.; Vos L.M., Bentala M., Geuzebroek G.S., Molhoek S.G., van Putte B.P. Long-term outcome after totally thoracoscopic ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31(1):40-45. doi:10.1111/jce.14267.; Choi M.S., On Y.K., Jeong D.S., Park K.M., Park S.J., Kim J.S., Carriere K.C. Usefulness of Postprocedural Electrophysiological Confirmation Upon Totally Thoracoscopic Ablation in Persistent Atrial Fibrillation. Am J Cardiol. 2020;125(7): 1054-1062. doi:10.1016/j.amjcard.2019.12.046.; Hong K.N., Russo M.J., Liberman E.A., Trzebucki A., Oz M.C., Argenziano M., Williams M.R. Effect of epicardial fat on ablation performance: a three-energy source comparison. J Card Surg. 2007; 22:521–524. doi:10.1111/j.1540-8191.2007.00454.x.; Osmancik P., Budera P., Zdarska J., Herman D., Petr R., Straka Z. Electrophysiological findings after surgical thoracoscopic atrial fibrillation ablation. Heart Rhythm. 2016;13: 1246–1252. doi:10.1016/j.hrthm.2016.02.007.; Lin J., Scherlag B.J., Lu Z., Zhang Y., Liu S., Patterson E., Jackman W.M., Lazzara R., Po S.S. Inducibility of atrial and ventricular arrhythmias along the ligament of marshall: role of autonomic factors. J Cardiovasc Electrophysiol. 2008;19:955-962. doi:10.1111/j.1540-8167.2008.01159.x.; Hocini M., Jaïs P., Sanders P., Takahashi Y., Rotter M., Rostock T., Hsu L.F., Sacher F., Reuter S., Clémenty J., Haïssaguerre M. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation. 2005;112:3688–96. doi:10.1161/CIRCULATIONAHA.105.541052.; Phan K., Xie A., Tsai Y.C., Kumar N., La Meir M., Yan T.D. Biatrial ablation vs. left atrial concomitant surgical ablation for treatment of atrial fibrillation: a meta-analysis. Europace. 2015;17(1):38–47. doi:10.1093/europace/euu220.; Edgerton J.R., Jackman W.M., Mack M.J. A new epicardial lesion set for minimal access left atrial maze: the Dallas lesion set. Ann Thorac Surg. 2009;88(5):1655-1657. doi:10.1016/j.athoracsur.2009.05.046.; Weimar T., Vosseler M., Czesla M., Boscheinen M., Hemmer W.B., Doll K.N. Approaching a paradigm shift: endoscopic ablation of lone atrial fibrillation on the beating heart. Ann Thorac Surg. 2012;94:1886-1892. doi:10.1016/j.athoracsur.2012.07.035.; Sirak J., Jones D., Schwartzman D. The five-box thoracoscopic maze procedure. Ann Thorac Surg. 2010;90(3):986-9. doi:10.1016/j.athoracsur.2010.05.022.; Guo Q.Z., Zhu D., Bai Z.X., Shi J., Shi Y.K., Guo Y.Q. A novel "box lesion" minimally invasive totally thoracoscopic surgical ablation for atrial fibrillation. Ann Acad Med Singap. 2015;44(1):6-12.; Doty J.R., Clayson S.E. Surgical Treatment of Isolated (Lone) Atrial Fibrillation With Gemini-S Ablation and Left Atrial Appendage Excision (GALAXY Procedure). Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2012.7(1):33–38. doi:10.1097/imi.0b013e3182560612.; Антикеев А.М., Шамуратов И.К., Дюржанов А.А., Даиров Д.С., Абильтаев А.М., Ерболатов Б.Н., Курманов А.М., Накипов Х.Х. Торакоскопическая радиочастотная аблация для лечения фибрилляции предсердий. Оперативная техника и непосредственные результаты трех клинических случаев. Анналы аритмологии. 2017; 14(3): 150-154. doi:10.15275/annaritmol.2017.3.4; Janusauskas V., Puodziukaite L., Maneikiene V.V., Zuoziene G., Radauskaite G., Burneikaite G., Samalavicius R.S., Aidietiene S., Rucinskas K., Aidietis A. Long-term results of minimally invasive stand-alone bi-atrial surgical ablation with a bipolar ablation device for persistent and longstanding persistent AF: a single center case series of 91 patients. J Cardiothorac Surg. 2016; 11(1): 23-31. doi:10.1186/s13019-016-0416-0.; Harlaar N., Oudeman M.A., Trines S.A., de Ruiter G.S., Mertens B.J., Khan M., Klautz R.J.M., Zeppenfeld K., Tjon A., Braun J., van Brakel T.J. Long-term follow-up of thoracoscopic ablation in long-standing persistent atrial fibrillation. Interact Cardiovasc Thorac Surg. 2022;34(6):990-998. doi:10.1093/icvts/ivab355.; Harlaar N., Verberkmoes N.J., van der Voort P.H., Trines S.A., Verstraeten S.E., Mertens B.J.A., Klautz R.J.M., Braun J., van Brakel T.J. Clamping versus nonclamping thoracoscopic box ablation in long-standing persistent atrial fibrillation. J Thorac Cardiovasc Surg. 2020;160:399–405. doi:10.1016/j.jtcvs.2019.07.104.; Fleerakkers J., Hofman F.N., van Putte B.P. Totally thoracoscopic ablation: a unilateral right-sided approach. Eur J Cardiothorac Surg. 2020 Nov 1;58(5):1088-1090. doi:10.1093/ejcts/ezaa160.; Bisleri G., Manzato A., Argenziano M., Vigilance D.W., Muneretto C. Thoracoscopic epicardial pulmonary vein ablation for lone paroxysmal atrial fibrillation. Europace. 2005 Mar;7(2):145-8. doi:10.1016/j.eupc.2004.12.005.; Haywood G.A., Varini R., Osmancik P., Cireddu M., Caldwell J., Chaudhry M.A., Loubani M., Della Bella P., Lapenna E., Budera P., Dalrymple-Hay M. European multicentre experience of staged hybrid atrial fibrillation ablation for the treatment of persistent and longstanding persistent atrial fibrillation. Int J Cardiol Heart Vasc. 2020;26:100459. doi:10.1016/j.ijcha.2019.100459.; Rosati F., Muneretto C., Merati E., Polvani G., Moltrasio M., Tondo C., Curnis A., Cerini M., Metras A., Bisleri G. Epicardial, Biatrial Ablation With Integrated Uni-bipolar Radiofrequency Technology in Stand-alone Persistent Atrial Fibrillation. Innovations (Phila). 2018;13(2):114-119. doi:10.1097/IMI.0000000000000482.; Muneretto C., Bisleri G., Bontempi L., Curnis A. Durable staged hybrid ablation with thoracoscopic and percutaneous approach for treatment of long-standing atrial fibrillation: a 30-month assessment with continuous monitoring. J Thorac Cardiovasc Surg. 2012;144: 1460 – 5. doi:10.1016/j.jtcvs.2012.08.069.; Артюхина Е.А., Ревишвили А.Ш., Малашенко Е.С., Мунеретто С. Первый опыт устранения длительно-персистирующей формы фибрилляции предсердий с использованием торакоскопической радиочастотной аблации. Инновационная медицина Кубани. 2017;5(1):23-27.; Muneretto C., Bisleri G., Rosati F., Krakor R., Giroletti L., Di Bacco L., Repossini A., Moltrasio M., Curnis A., Tondo C., Polvani G. European prospective multicentre study of hybrid thoracoscopic and transcatheter ablation of persistent atrial fibrillation: the HISTORIC-AF trial. Eur J Cardiothorac Surg. 2017;52(4):740-745. doi:10.1093/ejcts/ezx162.; Maesen B., La Meir M. Unilateral Left-sided Thoracoscopic Ablation of Atrial Fibrillation. Ann Thorac Surg. 2020 Jul;110(1):e63-e66. doi:10.1016/j.athoracsur.2020.01.057.; Ellis C.R., Badhwar N., Tschopp D., Danter M., Jackson G.G., Kerendi F., Walters T., Fang Q., Deuse T., Beygui R., Lee R.J. Subxiphoid Hybrid Epicardial-Endocardial Atrial Fibrillation Ablation and LAA Ligation: Initial Sub-X Hybrid MAZE Registry Results. JACC Clin Electrophysiol. 2020;6(13):1603-1615. doi:10.1016/j.jacep.2020.06.011.; Wats K., Kiser A., Makati K., Sood N., DeLurgio D., Greenberg Y., Yang F. The Convergent AF Ablation Procedure: Evolution of a Multidisciplinary Approach to AF Management. Arrhythmia & Electrophysiology Review. 2020;9(2):88–96. doi:10.15420/aer.2019.20.; Kiser A.C., Landers M., Horton R., Hume A., Natale A., Gersak B. The convergent procedure: a multidisciplinary atrial fibrillation treatment. Heart Surg Forum. 2010;13:317–21. doi:10.1532/HSF98.20091112.; Zembala M., Filipiak K., Kowalski O., Boidol J., Sokal A., Lenarczyk R., Niklewski T., Garbacz M., Nadziakiewicz P., Kalarus Z., Zembala M. Minimally invasive hybrid ablation procedure for the treatment of persistent atrial fibrillation: one year results. Kardiol Pol. 2012;70:819–28.; Gehi A.K., Mounsey J.P., Pursell I., Landers M., Boyce K., Chung E.H., Schwartz J., Walker T.J., Guise K., Kiser A.C. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm. 2013;10:22–8.; Gersak B., Jan M. Long-term success for the convergent atrial fibrillation procedure: 4-year outcomes. Ann Thorac Surg. 2016;102:1550–7. doi:10.1016/j.athoracsur.2016.04.018.; Хоменко Е.А., Мамчур С.Е., Козырин К.А., Тарасов Р.С., Баковский К.В. Ближайшие и среднесрочные результаты торакоскопической радиочастотной аблации фибрилляции предсердий. Комплексные проблемы сердечно-сосудистых заболеваний. 2019; 8 (4S): 82-88. doi:10.17802/2306-1278-2019-8-4S-82-88.; van der Heijden C.A.J., Weberndörfer V., Luermans J.G.L.M., Chaldoupi S.M., van Kuijk S.M.J., Vroomen M., Bidar E., Maessen J.G., Pison L., La Meir M., Maesen B. Hybrid ablation of atrial fibrillation: A unilateral left-sided thoracoscopic approach. J Card Surg. 2022;37(12):4630-4638. doi:10.1111/jocs.17144.; Maesen B., van der Heijden C.A.J., Bidar E., Vos R., Athanasiou T., Maessen J.G. Patient-reported quality of life after stand-alone and concomitant arrhythmia surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2022;34(3):339-348. doi:10.1093/icvts/ivab282.

Availability: https://www.nii-kpssz.com/jour/article/view/1335
https://doi.org/10.17802/2306-1278-2023-12-2-107-121

Синтопия устьев лёгочных вен в левом предсердии сердца человека ; Syntopy of Pulmonary Vein Orifices in the Left Atrium of the Human Heart

Authors: Gaponov, A. A., Noskova, M. E., Yakimov, A. A., Гапонов, А. А., Носкова М. Е., Якимов А. А.

Subject Terms: HUMAN HEART ANATOMY, HEART MORPHOMETRY, HEART, LEFT ATRIUM, PULMONARY VEINS, OVAL FOSSA, АНАТОМИЯ СЕРДЦА ЧЕЛОВЕКА, МОРФОМЕТРИЯ СЕРДЦА, СЕРДЦЕ, ЛЕВОЕ ПРЕДСЕРДИЕ, ЛЁГОЧНЫЕ ВЕНЫ, ОВАЛЬНАЯ ЯМКА

File Description: application/pdf

Relation: Scopus; http://elib.usma.ru/handle/usma/6965

Availability: http://elib.usma.ru/handle/usma/6965

Функция левого предсердия у больных хронической сердечной недостаточностью

Authors: Перуцкий, Д. Н., Обрезан, А. Г., Осипова, О. А., Зарудский, А. А.

Subject Terms: медицина, внутренние болезни, кардиология, болезни сердца, хроническая сердечная недостаточность, левый желудочек, левое предсердие

Relation: http://dspace.bsu.edu.ru/handle/123456789/52620

Availability: http://dspace.bsu.edu.ru/handle/123456789/52620

ЛУЧЕВЫЕ МЕТОДЫ ОЦЕНКИ ФУНКЦИИ ЛЕВОГО ПРЕДСЕРДИЯ ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ (ОБЗОР ЛИТЕРАТУРЫ)

Subject Terms: магнитно-резонансная томография, high-density mapping, компьютерная томография, фибрилляция предсердий, высокоплотное картирование, левое предсердие, echocardiography, magnetic resonance imaging, atrial fibrillation, computed tomography, 3. Good health, эхокардиография, left atrium

Factors for the development of atrial fibrillation after open heart surgery ; Факторы развития фибрилляции предсердий после операции на «открытом» сердце

Authors: D. I. Lebedev, A. V. Evtushenko, A. A. Khorlampenko, Д. И. Лебедев, А. В. Евтушенко, А. А. Хорлампенко

Source: Complex Issues of Cardiovascular Diseases; Том 10, № 2 (2021): приложение; 40-44 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 10, № 2 (2021): приложение; 40-44 ; 2587-9537 ; 2306-1278

Subject Terms: левое предсердие, open heart surgery, C-reactive protein, left atrium, «открытое» вмешательство, С-реактивный белок

File Description: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/922/577; Chugh S.S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E.J., Gillum R.F., Kim Y.H., McAnulty J.H. Jr., Zheng Z.J., Forouzanfar M.H., Naghavi M., Mensah G.A., Ezzati M., Murray C.J. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-47. doi:10.1161/CIRCULATIONAHA.113.005119.; Zulkifly H., Lip G.Y.H., Lane D.A. Epidemiology of atrial fibrillation. Int J Clin Pract. 2018;72(3):e13070. doi:10.1111/ijcp.13070.; Fontaine G.H. New Mechanisms of Atrial Fibrillation. Int. Cardiol. J. 2017; 3( 1): 10.; Echahidi N., Pibarot P., O'Hara G., Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51(8):793-801. doi:10.1016/j.jacc.2007.10.043.; Евтушенко А.В., Евтушенко В.В., Павлюкова Е.Н., Попов С.В. Монополярная радиочастотная аблация длительно персистирующей фибрилляции предсердий у пациентов с пороками сердца и хронической сердечной недостаточностью. Томск: НИИ кардиологии, Томский НИМЦ. 2019.; Rostagno C., Blanzola C., Pinelli F., Rossi A., Carone E, Stefàno P. L. Atrial fibrillation after isolated coronary surgery. Incidence, long term effects and relation with operative technique Heart Lung Vessel. 2014; 6(3): 171–179.; Gibson P.H., Cuthbertson B.H., Croal B.L., Rae D., El-Shafei H., Gibson G., Jeffrey R.R., Buchan K.G., Hillis G.S. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010 Jan 15;105(2):186-91. doi:10.1016/j.amjcard.2009.09.007.; Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., Tracy R.P., Van Wagoner D.R., Psaty B.M., Lauer M.S., Chung M.K. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003 Dec 16;108(24):3006-10. doi:10.1161/01.CIR.0000103131.70301.4F.; Kim M.N., Lee J.J., Kim S.A., Kim Y.H., Choi J.I., Park S.M., Park S.W., Kim Y.H., Shim W.J. The difference of predictors for recurrence after catheter ablation of nonparoxysmal atrial fibrillation according to follow-up period. Int Heart J. 2014;55(4):312-8. doi:10.1536/ihj.13-370.; Ревишвили А.Ш., Нардая Ш.Г., Рзаев Ф.Г., Мустапаева З.В., Котанова Е.С. Электрофизиологические и клинические предикторы эффективности радиочастотной аблации легочных вен и левого предсердия у пациентов с персистирующей формой фибрилляции предсердий. Анналы аритмологии. 2014;11(1):46-53. doi:10.15275/annaritmol.2014.1.6

Availability: https://www.nii-kpssz.com/jour/article/view/922
https://doi.org/10.17802/2306-1278-2021-10-2S-40-44

ВЛИЯНИЕ РАДИОЧАСТОТНОЙ И КРИОБАЛЛОННОЙ КАТЕТЕРНОЙ АБЛАЦИИ НА ФУНКЦИЮ ЛЕВОГО ПРЕДСЕРДИЯ У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ ПО ДАННЫМ МУЛЬТИСПИРАЛЬНОЙ КОМПЬЮТЕРНОЙ ТОМОГРАФИИ

Subject Terms: фибрилляция предсердий, cryoballoon catheter ablation, левое предсердие, мультиспиральная компьютерная томография, радиочастотная катетерная аблация, atrial fibrillation, multidetector computed tomography, radiofrequency catheter ablation, криобаллонная катетерная аблация, 3. Good health, left atrium

ROBOTIC CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION (RANDOMIZED TRIAL RESULTS)

Authors: M. A. Naymushin, D. S. Lebedev

Source: Российский кардиологический журнал, Vol 0, Iss 12, Pp 68-72 (2017)

Subject Terms: фибрилляция предсердий, легочные вены, RC666-701, левое предсердие, трепетание предсердий, 0202 electrical engineering, electronic engineering, information engineering, Diseases of the circulatory (Cardiovascular) system, 02 engineering and technology, роботизированная катетерная аблация, 3. Good health

Access URL: https://doaj.org/article/2d72ed9199a24e13bb23a5428a130f07
https://cyberleninka.ru/article/n/robotizirovannaya-kateternaya-ablatsiya-persistiruyuschey-fibrillyatsii-predserdiy-rezultaty-randomizirovannogo-issledovaniya
https://russjcardiol.elpub.ru/jour/article/download/2559/2228
https://russjcardiol.elpub.ru/jour/article/view/2559

Features of Structural and Functional Changes in the Heart in Elderly Patients with Coronary Heart Disease and Atrial Fibrillation ; Структурные и функциональные изменения миокарда у больных пожилого возраста с ишемической болезнью сердца и фибрилляцией предсердий

Authors: L. Folomeeva I., E. Filippov V., Л. Фоломеева И., Е. Филиппов В.

Source: Rational Pharmacotherapy in Cardiology; Vol 16, No 4 (2020); 536-541 ; Рациональная Фармакотерапия в Кардиологии; Vol 16, No 4 (2020); 536-541 ; 2225-3653 ; 1819-6446

Subject Terms: coronary heart disease, atrial fibrillation, left atrium, supraventricular arrhythmias, left ventricle, ишемическая болезнь сердца, фибрилляция предсердий, левое предсердие, суправентрикулярные аритмии, левый желудочек

File Description: application/pdf

Relation: https://www.rpcardio.com/jour/article/view/2250/2010; Chugh S.S., Havmoeller R., Narayanan K., et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-47. DOI:10.1161/CIRCULATIONAHA.113.005119.; 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37(38):2893-962. DOI:10.1093/eurheartj/ehw210.; Ревишвили А.Ш., Рзаев Ф.Г., Горев М.В. и др. Диагностика и лечение фибрилляции предсердий: клинические рекомендации [цитировано 04.07.2019]. Доступно на: https://racvs.ru/clinic/files/2017/Atrial-Fibrillation.pdf.; Mlynarska A., Mlynarsky R., Golba K.S. Older age and a higher EHRA score allow higher levels of frailty syndrome to be predicted in patients with atrial fibrillation. Aging Male. 2017;20(1):23-7. DOI:10.1080/13685538.2016.1241761.; Медведев Н.В., Горшунова Н.К. Возрастассоциированная саркопения как фактор риска развития миокардиальной дисфункции и хронической сердечной недостаточностью у больных пожилого возраста с артериальной гипертензией. Успехи Геронтологии. 2012;25(3):456-60.; Forouzanfar M.H., Alexander L., Anderson H.R., et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287-323. DOI:10.1016/S0140-6736(15)00128-2.; Mills K.T., Bundy J.D., Kelly T.N., et al. Global disparities of hypertension prevalence and control: asystematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441-50. DOI:10.1161/CIRCULATIONAHA.115.018912.; Cleland J.G., Pellicori P., Dierckx R. Clinical trials in patients withheart failure and preserved left ventricular ejection fraction. Heart Fail Clin. 2014;10:511-23. DOI:10.1016/j.hfc.2014.04.011.; Kotecha D., Lam C.S.P., Van Veldhuisen D.J., et al. Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins. J Am Coll Cardiol. 2016;68(20):2217-28. DOI:10.1016/j.jacc.2016.08.048.; Vermond R.A., Geelhoed B., Verweij N., et al. Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands. J Am Coll Cardiol. 2015;66:1000-7. DOI:10.1016/j.jacc.2015.06.1314.; O'Neal W.T., Sandesara P., Patel N., et al. Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction. Eur Heart J Cardiovasc Imaging. 2017;18(7):725- 9. DOI:10.1093/ehjci/jex038.; Kirchhof P., Benussi S., Kotecha D., et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-962. DOI:10.1093/eurheartj/ehw210.; Freedman B., Camm J., Calkins H., et al. Screening for atrial fibrillation: areport of the AF-SCREEN International Collaboration. Circulation. 2017;135:1851-67. DOI:10.1161/CIRCULATIONAHA.116.026693.; Ермошкин В.И. Причины сердечно сосудистых заболеваний. Новые гипотезы. Москва: Нобель Пресс; 2013.; Кац Я.А., Пархонюк Е.В., Корсунова Е.Н. и др. Хроническая склеротическая болезнь. Современные Проблемы Науки и Образования. 2015;1:1 [цитировано 04.07.2019]. Доступно на: http://www.science-education.ru/ru/article/view?id=19162; https://www.rpcardio.com/jour/article/view/2250

Availability: https://www.rpcardio.com/jour/article/view/2250
https://doi.org/10.20996/1819-6446-2020-2020-08-17

Thrombus of left atrium and/or its appendage in nonvalvular atrial fibrillation: echocardiographic and laboratory risk factors, capabilities for prediction and correction ; Тромбоз левого предсердия и/или его ушка при неклапанной фибрилляции предсердий: эхокардиографические и лабораторные факторы риска, возможности прогнозирования и коррекции

Authors: I. A. Zaigraev, I. S. Yavelov, И. А. Заиграев, И. С. Явелов

Source: Aterotromboz = Atherothrombosis; № 1 (2020); 56-70 ; Атеротромбоз; № 1 (2020); 56-70 ; 2658-5952 ; 2307-1109 ; 10.21518/2307-1109-2017-3

Subject Terms: предикторы, non-valvular atrial fibrillation, left atrium, left atrial appendage, thrombosis, risk factors, predictors, неклапанная фибрилляция предсердий, левое предсердие, ушко левого предсердия, тромбоз, факторы риска

File Description: application/pdf

Relation: https://www.aterotromboz.ru/jour/article/view/214/239; January C.T., Wann L.S., Alpert J.S., Calkins H., Cigarroa J.E., Cleveland J.C. Jr. et aL 2014 AHA/ ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):2071-2104. doi:10.1161/CIR.0000000000000040.; Scherr D., Dalai D., ChiLukuri K., Dong J., Spragg D., Henrikson C.A. et aL. Incidence and predictors of Left atriaL thrombus prior to catheter abLation of atrial fibrillation 2009. J Cardiovasc Electrophysiol. 2009;20(4):379-384. doi:10.1111/j.1540-8167.2008.01336.x.; Kirchhof P., Benussi S., Kotecha D., AhLsson A., Atar D., Casadei B. et aL. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962. doi:10.1093/eurheartj/ehw210.; Beigel R., Wunderlich N.C., Ho S.Y, Arsanjani R., Siegel R.J. The Left atrial appendage: anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging. 2014;7(12):1251-1265. doi:10.1016/j.jcmg.2014.08.009.; Frenkel D., D'Amato S.A., Markowitz S.M., Liu C.F., Thomas G., Ip J.E. et al. Prevalence ofleft atrial thrombus detection by transesophageal echocardiography a comparison of continuous non-vitamin K antagonist oral anticoagulant versus warfarin therapy in patients undergoing catheter ablation for atrial fibrillation. JACC Clin Electrophysiol. 2016;2(3):295-303. doi:10.1016/j.jacep.2016.01.004.; Stoddard M.F., Singh P., Buddhadeb D., Longaker R. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J. 2003;145(4):676-682. doi:10.1067/mhj.2003.91.; Doukky R., KhandeLwaL A., Garcia-Sayan E. External vaHdation of a novel transthoracic echocardiographic tool in predictingLeft atrial appendage thrombus formation in patients with nonvalvular atrial fibriUation. Eur Heart J Cardiovasc Imaging. 2013;14(9):876-881. doi:10.1093/ehjci/jes313.; Kawabata M., Goya M., Sasaki T., Maeda S., Shirai Y., Yoshitake T. et al. Left atrial appendage thrombi formation in Japanese non-valvular atrial Н^^^п patients during anticoaguLation therapy - Warfarin vs. Direct Oral Anticoagulants. Circ J. 2017;81(5):645-651. doi:10.1253/circj.CJ-16-1089.; Blustin J.M., McBane R.D., Mazur M., Ammash N., Sochor O., GriU D.E., Wysokinski W.E. The association between thromboembolic complications and blood group in patients with atrial fibriUation. Mayo Clin Proc. 2015;90(2):216-223. doi:10.1016/j.mayocp.2014.11.013.; Заиграев И.А., Явелов И.С. Тромбоз левого предсердия и/или его ушка при неклапанной фибрилляции предсердий: частота выявления и клинические факторы риска. Атеротромбоз. 2019(2):68-79. doi:10.21518/2307-1109-2019-2-68-79.; Jenkins P.V., O'Donnell J.S. ABO blood group determines plasma von Willebrand factorlev-els: a biologic function after all? Transfusion. 2006;46(10):1836-1844. doi:10.1111/j.1537-2995.2006.00 975.x.; Guo Y., Lip G.Y.H., Apostolakis S. Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism. Curr Vasc Pharmacol. 2015;13(2):192-201. doi:10.2174/15701611113116660165.; Meus R., Son M., Sobczyk D. Prothrombotic state in patients with aleft atrial appendage thrombus of unknown origin and cerebrovascular events. Stroke. 2016;47(7):1872-1878. doi:10.1161/STROKEAHA.116.012856.; Yuan Fu, Kuibao Li, Xinchun Yang. ABO blood groups: a risk factor forleft atrial andleft atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation. Thromb Res. 2017;156:45-50. doi:10.1016/j.thromres.2017.05.018.; Kaya A., Tukkan C., Alper A.T., Gungor B., Ozcan K.S., Tatlisu M.A. et al. Increasedlevels of red cell distribution width is correlated with presence ofleft atrial stasis in patients with non-valvular atrial fibrillation. North Clin Istanb. 2017;4(1):66-72. doi:10.14744/nci.2017.72324.; Lappe J.M., Horne B.D., Shah S.H., May H.T., Muhlestein J.B., Lappe D.L. et al. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clin Chim Acta. 2011;412(23-24):2094-2099. doi:10.1016/j.cca.2011.07.018.; Providencia R., Ferreira M.J., Gonsalves L., Paiva L., Fernandes A., Barra S. et al. Mean corpuscular volume and red cell distribution width as predictors of left atrial stasis in patients with non-valvular atrial fibrillation. Am J Cardiovasc Dis. 2013;3(2):91-102. Available at: https://europepmc.org/article/pmc/pmc3683407#abstract; Ulu S.M., Ozkeqeci G., Akci O., Ahsen A., Altug A., Demir K., Acarturk G. Mean platelet volume, in predicting severity of mitral regurgitation and left atrial appendage thrombosis. Blood Coagul Fibrinolysis. 2014;25(2):119-124. doi:10.1097/MBC.0b013e328364c453.; Hong-ling Yang, Yong-Ping Lin, Yan Long, Qing-ling Ma, Cheng Zhou. Predicting cardioembolic stroke with the B-type natriuretic peptide test: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2014;23(7):1882—1889. doi:10.1016/j.jstrokecere-brovasdis.2014.02.014.; Pant R., Patel M., Garcia-Sayan E., Wassouf M., D'Silva O., Kehoe R.F., Doukky R. Impact of B-type natriuretic peptidelevel on the risk ofleft atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study. Cardiovasc Ultrasound. 2015;14:4. doi:10.1186/s12947-016-0047-6.; Doukky R., Gage H., Nagarajan V., Demopoulos A., Cena M., Garcia-Sayan E. et al. B-type natriuretic peptide predictsleft atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography. 2013;30(8):889-895. doi:10.1111/echo.12169.; Ochiumi Y., Kagawa E., Kato M., Sasaki S., Nakano Y., Itakura K. et al. Usefulness of brain natriuretic peptide for predictingleft atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation. J Arrhythm. 2015;31:307-312. doi:10.1016/j.joa.2015.04.002.; Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(4):412. doi:10.1093/ehjci/jew041.; Mancia G., Fagard R., Narkiewicz K., Redan J., Zanchetti A., Bohm M. et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-1238. doi:10.1097/HJH.0b013e328364ca4c.; Boyd A.C., McKay T., Nasibi S., Richards D.A.B., Thomas L. Left ventricular mass predictsleft atrial appendage thrombus in persistent atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2013;14(3):269-275. doi:10.1093/ehjci/jes153.; Faustino A., Providencia R., Barra S., Paiva L., Trigo J., Botelho A. et al. Which method ofleft atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation? Cardiovasc Ultrasound. 2014;12:28. doi:10.1186/1476-7120-12-28.; Ayirala S., Kumar S., O'Sullivan D.M., Silverman D.I. Echocardiographic predictors ofleft atrial appendage thrombus formation. J Am Soc Echocardiogr. 2011;24(5):499-505. doi:10.1016/j.echo.2011.02.010.; Doukky R., Khandelwal A., Garcia-Sayan E., Gage H. External validation of a novel transthoracic echocar-diographic tool in predictingleft atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2013;14(9):876-881. doi:10.1093/ehjci/jes313.; Doukky R., Garcia-Sayan E., Gage H., Nagarajan V., Demopoulos A., Cena M. et al. The value of diastolic function parameters in the prediction ofleft atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Cardiovasc Ultrasound. 2014;12:10. doi:10.1186/1476-7120-12-10.; Garcia-Sayan E.D., Patel M., Wassouf M., Pant R., D'Silva O.J., Kehoe R.F., Doukky R. Derivation and validation of E/e ratio as a parameter in the evalu-ation ofleft atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation. Int J Cardiovasc Imaging. 2016;32(9):1349-1356. doi:10.1007/s10554-016-0916-y.; Doukky R., Garcia-Sayan E., Patel M., Pant R., Wassouf M., Shah S. et al. Impact of diastolic function parameters on the risk forleft atrial appendage thrombus in patients with nonvalvular atrial fibril-lation: a prospective study. J Am Soc Echocardiogr. 2016;29(6):545-553. doi:10.1016/j.echo.2016.01.014.; Sasaki S., Watanabe T., Tamura H., Nishiyama S., Wanezaki M., Sato C. et al. Left atrial strain as evalu-ated by two-dimensional speckle tracking predicts left atrial appendage dysfunction in patients with acute ischemic stroke. BBA Clin. 2014;2:40-47. doi:10.1016/j.bbacli.2014.09.004.; Wang Y., Li M., Zhong L., Ren S., Li H., Tang Y. et al. Left Atrial Strain as Evaluated by Two-Dimensional Speckle Tracking Predicts Left Atrial Appendage Dysfunction in Chinese Patients with Atrial Fibrillation. Cardiology Research and Practice, 2020;2020:1-8. doi:10.1155/2020/5867617.; Piccini J.P., Sievert H., Patel M.R. Left atrial appendage occlusion: rationale, evidence, devices, and patient selection. Eur Heart J. 2017. 21;38(12):869-876. doi:10.1093/eurheartj/ehw330.; Tan N.Y., Yasin O.Z., Sugrue A., Sabbagh A.E., Foley T.A., Asirvatham S.J. Anatomy and Physiologic Roles of the Left Atrial Appendage: Implications for Endocardial and Epicardial Device Closure. Interv Cardiol Clin. 2018;7(2):185-199. doi:10.1016/j.iccl.2017.12.001.; Tilz R.R., Potpara T., Chen J., Dobreanu D., Larsen T.B., Haugaa K.H., Dagres N. Left atrial appendage occlude implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey. Europace. 2017;19(10):1737-1742. doi:10.1093/euro-pace/eux254.; Beigel R., Wunderlich N.C., Ho S.Y., Arsanjani R., Siegel R.J. Theleft atrial appendage: anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging. 2014;7(12):1251-1265. doi:10.1016/j.jcmg.2014.08.009.; Di Biase L., Santangeli P., Anselmino M., Mohanty P., Salvetti I., Gili S. et al. Does theleft atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60(6):531-538. doi:10.1016/j.jacc.2012.04.032.; Khurram I.M., Dewire J., Mager M., Maqboo F., Zimmerman S.L., Zipunnikov Z. et al. Relationship betweenleft atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm. 2013;10(12):1843-1849. doi:10.1016/j.hrthm.2013.09.065.; He J., Fu Z., Yang L., Liu W., Tian Y., Liu Q. et al. The predictive value of a concise classification ofleft atrial appendage morphology to thrombosis in non-valvular atrial fibrillation patients. Clin Cardiol. 2020. doi:10.1002/clc.23381.; Wang F., Zhu M., Wang X., Zhang W., Su Y., Lu Y. et al. Predictive value ofleft atrial appendagelobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord. 2018;18(1):153. doi:10.1186/s12872-018-0889-y.; Wang Y., Di Biase L., Horton R.P., Nguyen T., Morhanty P., Morhanty P., Natale A. Left Atrial Appendage Studied by Computed Tomography to Help Planning for Appendage Closure Device Placement Journal of Cardiovascular Electrophysiology. 2010;21(9):973-982. doi:10.1111/j.1540-8167.2010.01814.x.; Breitenstein A., Glanzmann M., Falk V., Maisano F., StampfH S.F., Holy E.W. et al. Increased prothrombotic profile in theleft atrial appendage of atrial fibrillation patients. Int J Cardiol. 2015;185:250-255. doi:10.1016/j.ijcard.2015.03.092.; Herrmann M., Whiting M.J., Veillard A.S., Ehnholm C., Sullivan D.R., Keech A.C. Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study. Clin Chem Lab Med. 2012;50(12):2213-2219. doi:10.1515/cclm-2012-0078.; Yan Yao, Mei-Sheng Shang, Li-Jian Gao, Jing-Hua Zhao, Xiao-Hui Yang, Tong Liu et al. Elevated homocysteine increases the risk ofleft atrial/left atrial appendage thrombus in non-vaivuiar atrial fibrillation withlow CHA2DS2-VASc score. Europace. 2018;20(7):1093-1098. doi:10.1093/europace/eux189.; Cengel A., Sahinarslan A., Biberoglu G., Hasanoglu A., Tavil Y., Tulmag M., Ozdemir M. Asymmetrical dimethy-largininelevel in atrial fibrillation. Acta Cardiol. 2008;63(1):33-37. doi:10.2143/ac.63.1.2025329.; Chao T.F., Lu T.M., Lin Y.J., Tsao H.-M., Chang S.-L., Lo L.-W. et al. Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. PLoS One. 2013;8(8):e71675. doi:10.1371/journal.pone.0071675.; Wei Xia, Yan Wang, Tongqing Duan, Yuanyuan Rong, Yifan Chi, Yibing Shao. Asymmetric dimethylarginine predictsleft atrial appendage thrombus in patients with non-valvular atrial fibrillation. Thromb Res. 2015;136(6):1156-1159. doi:10.1016/j.thromres.2015.10.021.; Ri-Bo Tang, Jian-Zeng Dong, Xian-Liang Yan, Xin Du, Jun-Ping Kang, Jia-Hui Wu et al. Serum uric acid and risk ofleft atrial thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol. 2014;30(11):1415-1421. doi:10.1016/j.cjca.2014.06.009.; Liu F.Z., Liao H.T., Lin W.D., Xue Y.-M., ZhanX.-Z., Fang X.-H. et al. Predictive effect of hyperuricemia onleft atrial stasis in non-valvular atrial fibrillation patients. Int J Cardiol. 2018;258:103-108. doi:10.1016/j.ijcard.2018.01.080.; Ning W., Li Y., Ma C., Qiu L., Yu B. The Refinement of Risk Stratification for Atrial Thrombus or Spontaneous Echo Contrast in Nonvalvular Atrial Fibrillation. Int Heart J. 2017;58(6):885-893. doi:10.1536/ihj.16-444.; Somloi M., Tomcsanyi J., Nagy E., Bodo I., Bexxegh A. D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation. The American Journal of Cardiology. 2003;92(1):85-87. doi:10.1016/s0002-9149(03)00476-4.; Sugiura S., Fujii E., Senga M., Sugiura E., Nakamura M., Ito M. Clinical features of patients withleft atrial thrombus undergoing anticoagulant therapy. J Interv Card Electrophysiol. 2012;34(1):59- 63. doi:10.1007/s10840-011-9633-6.; Pfluecke C., Tarnowski D., Plichta L., Berndt K., Schumacher P., Ulbrich S. et al. Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation. Clin Res Cardiol. 2016. 105(4):314-322. doi:10.1007/s00392-015-0922-4.; YuYang Chen, Qi Liu, Li Liu, Shu Xiao-Rong, Su Zi-Zhuo, Zhang Hai-Feng et al. Effect of metabolic syndrome on risk stratification forleft atrial orleft atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation. Chin Med J (Engl). 2016;129(20):2395-2402. doi:10.4103/0366-6999.191744.; Sikorska A., Baran J., Pilichowska-Paszkiet E., Sikora-Frgc M., Krynski T., Piotrowskiet R. et al. Risk ofleft atrial appendage thrombus in patients scheduled for ablation for atrial fibrillation: beyond the CHA2DS2VASc score. Pol Arch Inter Med. 2015;125(12):921-928. doi:10.20452/pamw.3213.; Kapton-Cieslicka A., Budnik M., Gawatko M., Peller M., Gorczyca I., Michalska A. et al. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus. Heart. 2019;105(17):1310-1315. doi:10.1136/heartjnl-2018-314492.; Nishikii-Tachibana M., Murakoshi N., Seo Y., Xu D., Yamamoto M., Ishizu T. et al. Prevalence and Clinical Determinants of Left Atrial Appendage Thrombus in Patients with Atrial Fibrillation Prior to Pulmonary Vein Isolation. Am J Cardiol. 2015;116(9):1368-1373. doi:10.1016/j.amjcard.2015.07.055.; Saeed M., Rahman A., Afzal A., Agoston I., Jammula P., Birnbaum Y. et al. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillatio, previousleft atrial thrombus and effective anticoagulation. Int J Cardiol. 2006;113(3):401-405. doi:10.1016/j.ijcard.2006.03.036.; Strach K., Meyer C., Hackenbroch M., Tiemann K., Haase J., Pizulli L. et al. Long-term fate ofleft atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy. Rofo. 2005;177(12):1706-1712. (In Germ.) doi:10.1055/s-2005-858787.; Bernhardt P., Schmidt H., Hammerstingl C., Hackenbroch M., Sommer T., Luderitz B., Omran H. Fate ofleft atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance Imaging. Am J Cardiol. 2004;94(6):801-804. doi:10.1016/j.amjcard.2004.06.010.; Bernhardt P., Schmidt H., Hammerstingl C., Luderitz B., Omran H. Atrial Thrombi - A Prospective Follow-up Study over 3 Years with Transesophageal Echocardiography and Cranial Magnetic Resonance Imaging. Echocardiography. 2006;23(5):388-394. doi:10.1111/j.1540-8175.2006.00225.x.; Lip G.Y.H., Hammerstingl C., Marin F., Cappato R., Ling Meng I., Kirsch B. et al. Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). Am Heart J. 2016;178:126-134. doi:10.1016/j.ahj.2016.05.007.; Ferner M., Wachtlin D., Konrad T., Deuster O., Meinertz T., von Bardeleben S. et al. Rationale and design of the RE-LATED AF - AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus - Effects of Dabigatran in patients with Atrial Fibrillation. Clin Res Cardiol. 2016;105(1):29-36. doi:10.1007/s00392-015-0883-7.; Hussain A., Katz W.E., Genuardi M.V., Bhonsale A., Jain S.K., Kancharla K. et al. Non-vitamin K oral anticoagulants versus warfarin forleft atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter. Pacing Clin Electrophysiol. 2019;42(9):1183-1190. doi:10.1111/pace.13765.; Niku A.D., Shiota T., Siegel R.J., Rader F. Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral Anticoagulation. Am J Cardiol. 2019;123(1):63-68. doi:10.1016/j.amjcard.2018.09.027.; Farkowski M.M., Jubele K., Marin F., Gandjbakhch E., Ptaszynski P., Merino J.L. et al. Diagnosis and management ofleft atrial appendage thrombus in patients with atrialfibrillation undergoing cardioversion or percutaneousleft atrial procedures: results of the European Heart Rhythm Association survey. EP Europace. 2020;22(1):162-169. doi:10.1093/euro-pace/euz257.; https://www.aterotromboz.ru/jour/article/view/214

Availability: https://www.aterotromboz.ru/jour/article/view/214
https://doi.org/10.21518/2307-1109-2020-1-56-70

THROMBUS OF LEFT ATRIUM AND/OR ITS APPENDAGE IN CASE OF NONVALVULAR ATRIAL FIBRILLATION: FREQUENCY OF DETECTION AND CLINICAL RISK FACTORS ; ТРОМБОЗ ЛЕВОГО ПРЕДСЕРДИЯ И/ИЛИ ЕГО УШКА ПРИ НЕКЛАПАННОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ: ЧАСТОТА ВЫЯВЛЕНИЯ И КЛИНИЧЕСКИЕ ФАКТОРЫ РИСКА

Authors: I. A. Zaigrayev, I. S. Yavelov, И. А. Заиграев, И. С. Явелов

Source: Aterotromboz = Atherothrombosis; № 2 (2019); 68-79 ; Атеротромбоз; № 2 (2019); 68-79 ; 2658-5952 ; 2307-1109 ; 10.21518/2307-1109-2019-2

Subject Terms: предикторы, non-valvular atrial fibrillation, left atrium, left atrial appendage, thrombosis, risk factors, predictors, неклапанная фибрилляция предсердий, левое предсердие, ушко левого предсердия, тромбоз, факторы риска

File Description: application/pdf

Relation: https://www.aterotromboz.ru/jour/article/view/200/229; Kirchhof P., Benussi S., Kotecha D. et. al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organization (ESO) fibrillation developed in collaboration with EACTS, 2016. European Heart Journal. 2016;37:2893–2962. doi:10.1093/eurheartj/ehw210.; January C.T., Wann S., Alpert J.S., et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2014;130(23):2071–104. doi:10.1161/CIR.0000000000000041.; Haim M., Hoshen M., Reges O., Rabi Y., Balicer R., Leibowitz M. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc. 2015;4(1):e001486 doi:10.1161 / JAHA.114.001486.; Scherr D., et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation 2009. J Cardiovasc Electrophysiol. 2009;20(4):379–84. doi:10.1111/j.1540–8167.2008.01336.x.; Hart R.G., et al. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857–867. doi:10.7326/0003–4819–146–12–200706190–00007.; Явелов И.С., Окшина Е.Ю. Атеротромботический инсульт при неклапанной фибрилляции предсердий. Неврология, нейропсихиатрия, психосоматика. 2019;11(3S):78–81. doi:10.14412/2074–2711-2019-3S-78–81.; Roldán V., Marín F., Manzano-Fernández S., Gallego P., et al. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2013;62(23):2199–204. doi:10.1016/j.jacc.2013.08.1623.; Hylek E.M., Go A.S., Chang Y., Jensvold N.G., Henault L.E., Selby J.V., Singer D.E. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349(11):1019–1026. doi:10.1056/NEJMoa022913.; Camm A.J., Kirchhof P., Lip G.Y.H., et al. Guidelines for the management of atrial fibrillation. The Task Force for the Managementof Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–1420. doi:10.1093/europace/euq350.; Ruff C.T., et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–962. doi:10.1016/S0140–6736(13) 62343–0.; Romero J., Cao J.J., Garcia M.J. et al. Cardiac imaging for assessment of left atrial appendage stasis and thrombosis. Nat Rev Cardiol. 2014;11(8):470–480. doi:10.1038/nrcardio.2014.77.; Hwang J.J., Chen J.J., Lin S.C., et аl. Diagnostic accuracy of transesophageal echocardiography for detecting left atrial thrombi in patients with rheumatic heart disease having undergone mitral valve operations. Am J Cardiol. 1993;72(9):67781. doi:10.1016/0002–9149(93) 90884-f.; Doukky R., Khandelwal A., Garcia-Sayan E. et al. External validation of a novel transthoracic echocardiographic tool in predicting left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2013;14(9):876–881. doi:10.1093/ehjci/jes313.; Chen J., Zhang H., Zhu D., Wang Y., et al. Cardiac MRI for detecting left atrial/left atrial appendage thrombus in patients with atrial fibrillation Meta-analysis and systematic review. Herz. 2019;44(5):390–397. doi:10.1007/s00059-017-4676–9.; Kitkungvan D., Nabi F., Ghosn M.G., et al. Detection of LA and LAA Thrombus by CMR in Patients Referred for Pulmonary Vein Isolation. JACC: Cardiovasc Imaging. 2016;9(7):809–818. doi:10.1016/j.jcmg.2015.11.029.; Jun Gu, Wei Hu, Xu Liu. The Value of Magnetic Resonance Imaging in Catheter Ablation of Atrial Fibrillation. Clin Cardiol. 2015;38(3):190–194. doi:10.1002/clc.22360.; Frenkel D., D’Amato S.A., Al-Kazaz M., et аl. Prevalence of left atrial thrombus detection by transesophageal echocardiography a comparison of continuous non – vitamin K antagonist oral anticoagulant versus warfarin therapy in patients undergoing catheter ablation for atrial fibrillation. JACC: Clin Electrophysiol. 2016;2(3):295–303. doi:10.1016/j.jacep.2016.01.004.; Malik R., Alyeshmerni D.M., Wang Z., et al. Prevalence and predictors of left atrial thrombus in patients with atrial fibrillation: is transesophageal echocardiography necessary before cardioversion? Cardiovasc Revasc Med. 2015;16(1):12–14. doi:10.1016/j.carrev.2014.12.009.; Yu-Yang Chen, Qi Liu, Li Liu, et al. Effect of metabolic syndrome on risk stratification for left atrial or left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation. Chin Med J (Engl). 2016;129(20):2395–2402. doi:10.4103/0366–6999.191744.; Anselmino M., Garberoglioa L., Gilia S., et al. Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study. Int J Cardiol. 2017;241:218–222. doi:10.1016/j.ijcard.2017.04.014.; Reers S., Agdirlioglu T., Kellner M., et al. Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists. Eur J Med Res. 2016;21(1):41. doi:10.1186/s40001-016-0235–8.; Sugiura E., Nakamura M., Ito M. Clinical features of patients with left atrial thrombus undergoing anticoagulant therapy. J Interv Card Electrophysiol. 2012;34(1):59–63. doi:10.1007/s10840-011-9633–6.; Bernhardt P., Schmidt H., Hammerstingl C., et. аl. Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance Imaging. Am J Cardiol. 2004;94(6):801–804. doi:10.1016/j.amjcard.2004.06.010.; Bernhardt P., Schmidt H., Hammerstingl C., et. аl. Atrial Thrombi – A Prospective Follow-up Study over 3 Years with Transesophageal Echocardiography and Cranial Magnetic Resonance Imaging. Echocardiography. 2006;23(5):388–394. doi:10.1111/j.1540–8175.2006.00225.x.; Doukky R., Garcia-Saya E., Patel M., et al. Impact of diastolic function parameters on the risk for left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study. J Am Soc Echocardiogr. 2016;29(6):545–553. doi:10.1016/j.echo.2016.01.014.; Boyd A.C., McKay T., Nasibi S. et al. Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2013;14(3):269–75. doi:10.1093/ehjci/jes153.; Wysokinski W.E., Ammash N., Sobande F., et al. Predicting left atrial thrombi in atrial fibrillation. Am Heart J. 2010;159(4):665–671. doi:10.1016/j.ahj.2009.12.043.; Milhem A., Ingrand P., Tréguer F., et al. Exclusion of Intra-Atrial Thrombus Diagnosis Using D–Dimer Assay Before Catheter Ablation of Atrial Fibrillation. JACC: Clin Electrophysiol. 2019;5(2):223–230. doi:10.1016/j.jacep.2018.09.009.; Ya Suo, Yue Zhang, Yuanyuan Wang, et аl. Reninangiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation. Cardiol J. 2018;25(5):611–620. doi:10.5603/CJ.a2017.0112.; Providкncia R., Fernandes A., Paiva L., Faustino A., et al. Decreased glomerular filtration rate and markers of left atrial stasis in patients with nonvalvular atrial fibrillation. Cardiology. 2013;124(1):3–10. doi:10.1159/000345434.; Sikorska A., Baran J., Pilichowska-Paszkiet E., et al. Risk of left atrial appendage thrombus in patients scheduled for ablation for atrial fibrillation: beyond the CHA2DS2VASc score. Pol Arch Med Wewn. 2015;125(12):921–928. doi:10.20452/pamw.3213.; Kapłon-Cieślicka A., Budnik M., Gawałko M., et al. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus. Heart. 2019;0:1–6. doi:10.1136/heartjnl-2018–314492.; Gunawardene M.A., Dickow J., Schaeffer B.N. et al. Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualizeduse of transesophageal echocardiography. J Cardiovasc Electrophysiol. 2017;28(10):1127–1136. doi:10.1111/jce.13279.; Ochiumi Y., Kagawa E., Kato M., et al. Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unantico-agulated nonvalvular persistent atrial fibrillation. J Arrhythm. 2015;31(5):307–312. doi:10.1016/j.joa.2015.04.002.; Huang J., Wu S.L., Xue Y.M., Fei H.W., Lin Q.W., et al. Association of CHADS2 and CHA2DS2-VASc Scores with Left Atrial Thrombus with Nonvalvular Atrial Fibrillation: A Single Center Based Retrospective Study in a Cohort of 2695 Chinese Subject. Biomed Res Int. 2017;2017:6839589. doi:10.1155/2017/6839589.; Yumei X., Jun H., Shulin W. GW24-e3109 correlation of CHADS2 and CHA2DS2-VASc scores with left atrial thrombus in Chinese patients with nonvalvular atrial fibrillation. Heart. 2013;99: A186. doi:10.1136/heartjnl-2013–304613.519.; Zoppo F., Brandolino G., Berton A. et al. Predictors of left atrium appendage clot detection despite on-target warfarin prevention for atrial fibrillation. J Interv Card Electrophysiol. 2012;35(2):151–158. doi:10.1007/s10840-012-9707–0.; Inoue K., Suna S., Iwakura K., Oka T., Masuda M., et al. Outcomes for atrial fibrillation patients with silent left atrial thrombi detected by transesophageal echocardiography. Am J Cardiol. 2017;120(6):940–946. doi:10.1016/j.amjcard.2017.06.022.; Stoddard M.F., Singh P., Dawn B. et. al. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J. 2003;145(4):676–682. doi:10.1067/mhj.2003.91.; Kawabata M., Goya M., Sasaki T., Maeda S., et al. Left atrial appendage thrombi formation in Japanese non-valvular atrial fibrillation patients during anticoagulation therapy – Warfarin vs. Direct Oral Anticoagulants. Circ J. 2017;81(5):645–651. doi:10.1253/circj.CJ-16–1089.; Fu Y., Li K., Yang X. ABO blood groups: a risk factor for left atrial and left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation. Thromb Res. 2017;156:45–50. doi:10.1016/j.thromres.2017.05.018.; Yalcin M., Mustafa Aparci, Omer Uz, Zafer Isilak, et al. Neutrophil-Lymphocyte ratio may predict left atrial thrombus in patients with nonvalvular atrial. Clin Appl Thromb Hemost. 2015;21(2):166–171. doi:10.1177/1076029613503398.; Kaya A., Tukkan C., Alper A.T., et al. Increased levels of red cell distribution width is correlated with presence of left atrial stasis in patients with non-valvular atrial fibrillation. North Clin Istanb. 2017;4(1):66–72. doi:10.14744/nci.2017.72324.; Ulua S.M., Akcib O., Ahsena A., et аl. Mean platelet volume, in predicting severity of mitral regurgitation and left atrial appendage thrombosis. Blood Coagul Fibrinolysis. 2014;25(2):119–124. doi:10.1097/MBC.0b013e328364c453.; Providência R., Ferreira M.J., Gonçalves L., et al. Mean corpuscular volume and red cell distribution width as predictors of left atrial stasis in patients with non-valvular atrial fibrillation. Am J Cardiovasc Dis. 2013;3(2):91–102. Available at: https://www.ncbi.nlm.nih.gov/pubmed/23785587/; Pant R., M. Patel, Garcia-Sayan E., et al. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study. Cardiovasc Ultrasound. 2016;(14):4. doi:10.1186/s12947-016-0047–6.; Doukky R., Nagarajan V., Demopoulos A., et al. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography. 2013;30(8):889–895. doi:10.1111/echo.12169.; Ochiumi Y., Kagawa E., Kato M., et al. Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation. J Arrhythm. 2015;31(5):307–312. doi:10.1016/j.joa.2015.04.002.; Ayirala S., Kumar S., O’Sullivan D.M., et al. Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr. 2011;24(5):499–505. doi:10.1016/j.echo.2011.02.010.; Faustino A., Providência R., Barra S., et аl. Which method of left atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation? Cardiovasc Ultrasound. 2014;(12):28. doi:10.1186/1476–7120–12–28.; Yao Y., Shang M.-s., Gao L.-J., et al. Elevated homocysteine increases the risk of left atrial/left atrial appendage thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score. Europace. 2018;20(7):1093–1098. doi:10.1093/europace/eux189.; Xia W., Wang Y., Duan T., et al. Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation. Thromb Res. 2015;136(6):1156–1159. doi:10.1016/j.thromres.2015.10.021.; Ri-Bo Tang, Jian-Zeng Dong, Xian-Liang Yan, et al. Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol. 2014;30(11):1415–1421. doi:10.1016/j.cjca.2014.06.009.; Somlói M., Tomcsányi J., Nagy E., et al. D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation. The American Journal of Cardiology. 2003;92:47–49. doi:10.1016/s0002–9149(03) 00476–4.; Sugiura S., Fujii E., Senga M., et al. Clinical features of patients with left atrial thrombus undergoing anticoagulant therapy. Interv Card Electrophysiol. 2012;34:59–63. doi:10.1007/s10840-011-9633–6.; Pfluecke C., Tarnowski D., Plichta L., et аl. Monocyte – platelet aggregates and CD11b expression as markersfor thrombogenicity in atrial fibrillation. Clin Res Cardiol. 2016;105(4):314–322. doi:10.1007/s00392-015-0922–4.; Nishikii-Tachibana M., Murakoshi N., Seo Y., et al. Prevalence and Clinical Determinants of Left Atrial Appendage Thrombus in Patients with Atrial Fibrillation Prior to Pulmonary Vein Isolation. Am J Cardiol. 2015;116(9):1368–1373. doi:10.1016/j.amjcard.2015.07.055.; Wallace T.W., Atwater B.D., Daubert J.P., et аl. Prevalence and Clinical Characteristics Associated With Left Atrial Appendage Thrombus in Fully Anticoagulated Patients Undergoing CatheterDirected Atrial Fibrillation Ablation. J Cardiovasc Electrophysiol. 2010;21(8):849–852. doi:10.1111/j.1540–8167.2010.01729.x.; Cohoon K.P., McBane R.D., et аl. Relationship between body mass index and left atrial appendage thrombus in nonvalvular atrial fibrillation. J Thromb Thrombolysis. 2016;41(4):613–618. doi:10.1007/s11239-015-1266–7.; Kupczynska K., Michalski B.W., Miskowiec D., et al. Association between left atrial function assessed by speckle-tracking echocardiography and the presence of left atrial appendage thrombus in patients with atrial fibrillation. Anatol J Cardiol. 2017;18(1):15–22. doi:10.14744/AnatolJCardiol.2017.7613.; Niku A.D., Shiota T., Siegel R.J., et al. Prevalence and Resolution of Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation and Flutter With Oral Anticoagulation. Am J Cardiol. 2019;123(1):63–68. doi:10.1016/j.amjcard.2018.09.027.; Lee W.C., Fang C.Y., Chen Y.L., Fang H.Y., Chen H.C., Liu W.H., Fu M., Chen M.C. Left Atrial or Left Atrial Appendage Thrombus Resolution After Adjustment of Oral Anticoagulant Treatment. J Stroke Cerebrovasc Dis. 2019;28(1):90–96. doi:10.1016/j.jstrokecerebrovasdis.2018.09.015.; Harada M., Koshikawa M., Motoike Y., et al. Left Atrial Appendage Thrombus Prior to Atrial Fibrillation Ablation in the Era of Direct Oral Anticoagulants. Circ J. 2018;82(11):2715–2721. doi:10.1253/circj.CJ-18–0398.; Niku A.D., Shiota T., Siegel R.J. et al. Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral Anticoagulation. Am J Cardiol. 2019;123(1):63–68. doi:10.1016/j.amjcard.2018.09.027.; Liu F.Z., Liao H.T., Lin W.D., Xue Y.M., Zhan X.Z., Fang X.H., et al. Predictive effect of hyperuricemia on left atrial stasis in nonvalvular atrial fibrillation patients. Int J Cardiol. 2018;258:103–108. doi:10.1016/j.ijcard.2018.01.080.; https://www.aterotromboz.ru/jour/article/view/200

Availability: https://www.aterotromboz.ru/jour/article/view/200
https://doi.org/10.21518/2307-1109-2019-2-68-79

Особенности структурно-функционального ремоделирования левого предсердия у пациентов с ишемической болезнью сердца и фибрилляцией предсердий по данным рутинной и speckle tracking эхокардиографии

Subject Terms: стрейн, ремоделирование, фиброз, ишемическая болезнь сердца, deformation, деформация, left atrium, фибрилляция предсердий, strain, fibrosis, левое предсердие, atrial fibrillation, speckle tracking эхокардиография, speckle tracking echocardiography, coronary artery disease, remodeling

ПЕРВЫЙ УСПЕШНЫЙ СЛУЧАЙ ТРАНСПЛАНТАЦИИ СЕРДЦА В ГОРОДЕ АЛМАТЫ: ГОДИЧНОЕ НАБЛЮДЕНИЕ

Subject Terms: giant left atrium, ортотопическая биатриальная трансплантация сердца, гигантское левое предсердие, хроническая сердечная недостаточность, orthotopic biatrial heart transplantation, chronic heart failure

Reliability of two-dimensional speckle tracking echocardiography in assessment of left atrial function in postmenopausal hypertensive women ; Надежность двухмерной спекл-трекинг эхокардиографии при оценке функции левого предсердия у женщин в состоянии менопаузы с гипертонической болезнью ; Надійність двовимірної спекл-трекінг ехокардіографії при оцінюванні функції лівого передсердя в жінок у стані менопаузи з гіпертонічною хворобою

Authors: Kolesnyk, M. Yu., Sokolova, M. V.

Source: Zaporozhye Medical Journal; Vol. 20 No. 1 (2018) ; Запорожский медицинский журнал; Том 20 № 1 (2018) ; Запорізький медичний журнал; Том 20 № 1 (2018) ; 2310-1210 ; 2306-4145

Subject Terms: speckle tracking echocardiography, left atrium, women, hypertension, menopause, спекл-трекинг эхокардиография, левое предсердие, женщины, гипертоническая болезнь, менопауза, спекл-трекінг ехокардіографія, ліве передсердя, жінки, гіпертонічна хвороба

File Description: application/pdf

Relation: http://zmj.zsmu.edu.ua/article/view/121875/118436; http://zmj.zsmu.edu.ua/article/view/121875

Availability: http://zmj.zsmu.edu.ua/article/view/121875

NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES ; ВПЕРВЫЕ ВОЗНИКШАЯ ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ В УСЛОВИЯХ ОСТРОГО КОРОНАРНОГО СИНДРОМА. АКТУАЛЬНЫЕ ВОПРОСЫ

Authors: G. Galjautdinov1 S., I. Gorelkin V., K. Ibragimova R., R. Sadriev R., Г. Галяутдинов С., И. Горелкин В., К. Ибрагимова Р., Р. Садриев Р.

Source: Rational Pharmacotherapy in Cardiology; Vol 14, No 3 (2018); 451-457 ; Рациональная Фармакотерапия в Кардиологии; Vol 14, No 3 (2018); 451-457 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2018-14-3

Subject Terms: atrial fibrillation, acute coronary syndrome, left atrium, asymptomatic atrial fibrillation, percutaneous coronary intervention, cardioembolic stroke, фибрилляция предсердий, острый коронарный синдром, левое предсердие, асимптомная фибрилляция предсердий, чрескожное коронарное вмешательство, кардиоэмболический инсульт

File Description: application/pdf

Relation: https://www.rpcardio.com/jour/article/view/1702/1677; Schmitt J., Duray G., Gersh B.J., Hohnloser S.H. Atrialfibrillationinacutemyocardialinfarction: asystematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038-45. doi:10.1093/eurheartj/ehn579.; Pérez-Villacastín J., Pérez Castellano N., Moreno Planas J. Epidemiology of Atrial Fibrillation in Spain in the Past 20 Years. Revista Española de Cardiología (English Edition). 2013;66(7):561-5. doi:10.1016/j.rec.2013.02.012.; Petersen P. Thromboembolic complications in atrial fibrillation. Stroke. 1990;21(1):4-13. doi:10.1161/01.STR.21.1.4.; Chugh S.S., Havmoeller R., Narayanan K., et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-47. doi:10.1161/CIRCULATIONAHA.113.005119.; Braga C.G., Ramos V., Martins J., et al. Impact of atrial fibrillation type during acute coronary syndromes: Clinical features and prognosis. Portuguese Journal of Cardiology. 2015;34(6):403-10. doi:10.1016/j.repc.2015.01.010.; Alshengeiti L., Elbarouni B., Yan R.T., et al. Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation. Canadian Journal of Cardiology. 2012;28(4):443-9. doi:10.1016/j.cjca.2011.12.011.; Jabre P., Jouven X., Adnet F., et al. Atrial fibrillation and death after myocardial infarction. Circulation. 2011;123(19):2094-100. doi:10.1161/CIRCULATIONAHA.110.990192.; Lehto M., Snapinn S., Dickstein K., et al. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J. 2004;26(4):350-6. doi:10.1093/eurheartj/ehi064.; González-Pacheco H., Márquez M.F., Arias-Mendoza A., et al. Clinical features and in -hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation. Journal of Cardiology. 2015;66(2):148-54. doi:10.1016/j.jjcc.2014.11.001.; Lopes R.D., Pieper K.S., Horton J.R., et al. Short-and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart (British Cardiac Society). 2008;94(7):867-73. doi:10.1136/hrt.2007.134486.; Ribeiro V., Pereira M., Melão F., et al. Determinants and outcomes of atrial fibrillation complicating myocardial infarction: the EURHOBOP study in Portugal. International Journal of Cardiology. 2014;176(3):1426-8. doi:10.1016/j.ijcard.2014.08.042.; Galvao Braga C., Ramos V., Vieira C., et al. New-onset atrial fibrillation during acute coronary syndromes: predictors and prognosis. Revista Portuguesa de Cardiologia (English Edition) 2014;33(5):281-7. doi:10.1016/j.repc.2013.10.017.; Consuegra-Sáncheza L., Melgarejo-Morenob A., Galcerá-Tomásc J., et al. Short-and long-term prognosis of previous and new-onset atrial fibrillation in ST-segment elevation acute myocardial infarction. Revista Española de Cardiología (English Edition). 2015;68(1):31-8. doi:10.1016/ j.rec.2014.03.017.; Jabre P., Roger V.L., Murad M.H., et al. Mortality associated with atrial fibrillation in patients with myocardial infarction. Circulation. 2011;123(15):1587-93. doi:10.1161/CIRCULATIONAHA.110.986661.; Lau D.H., Alasady M., Brooks A.G., et al. New-onset atrial fibrillation and acute coronary syndrome. Expert Review of Cardiovascular Therapy. 2010;8(7):941-8. doi:10.1586/erc.10.61.; Rathore S. S., Berger A. K., Weinfurt K. P., et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly. Circulation. 2000;101(9):969-74. doi:10.1161/01.CIR.101.9.969; Mehta R.H., Califf R.M., Yang Q., et al. Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock. The American Journal of Cardiology. 2007;99(6):793- 6. doi:10.1016/j.amjcard.2006.10.035.; Terkelsen C.J., Sorensen J.T., Kaltoft A.K., et al. Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. The American Journal of Cardiology. 2009;104(12)1641-6. doi:10.1016/j.amjcard.2009.07.037.; Tatli E., Alicik G., Buturak A., et al. Arrhythmias following revascularization procedures in the course of acute myocardial infarction: are they indicators of reperfusion or ongoing ischemia? The Scientific World Journal. 2013;2013:160380. doi:10.1155/2013/160380.; Rene A.G., Généreux P., Ezekowitz M., et al. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). The American Journal of Cardiology. 2014;113(2):236-42. doi:10.1016/j.amjcard.2013.09.016.; Wynn G.J., Todd D.M., Webber M., et al. The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification. Europace. 2014;16(7):965-72. doi:10.1093/europace/eut395.; Kirchhof P., Benussi S., Kotecha D., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organization (ESO). European Journal of Cardiothoracic Surgery. 2016;50(5):e1-e88. doi:10.1093/eurheartj/ehw210.; Siontis K.C., Gersh B.J., Killian J.M., et al. Typical, atypical, and asymptomatic presentations of newonset atrial fibrillation in the community: characteristics and prognostic implications. Heart Rhythm. 2016;13(7):1418-24. doi:10.1016/j.hrthm.2016.03.003.; Stamboul K., Zeller M., Fauchier L., et al. Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow up. Heart. 2015;101(11):864-9. doi:10.1136/heartjnl2014-307253.; Stamboul K., Zeller M., Fauchier L., Gudjoncik A. Incidence and prognostic significance of silent atrial fibrillation in acute myocardial infarction. International Journal of Cardiology. 2014;174(3):611-7. doi:10.1016/j.ijcard.2014.04.158.; Jons C., Jacobsen U.G., Joergensen R.M., et al. Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction (CARISMA) Study Group. The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy. Heart Rhythm. 2011;8(3):342-8. doi:10.1016/ j.hrthm.2010.09.090.; Senoo K., Lip G.Y. Prediction of stroke in patients without atrial fibrillation using the CHADS2 and CHA2DS2-VASc scores: a justification for more widespread thromboprophylaxis? Heart. 2014; 100(19):1485-6. doi:10.1136/heartjnl-2014-306161.; Chen M.C., Chang J.P., Liu W.H., et al. Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. The American Journal of Cardiology. 2008;102(7):861-5. doi:10.1016/j.amjcard.2008.05.038.; Platonov P.G., Mitrofanova L.B., Orshanskaya V., et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. Journal of the American College of Cardiology. 2011;58(21):2225-32. doi:10.1016/j.jacc.2011.05.061.; Kainuma S., Masai T., Yoshitatsu M., et al. Advanced left-atrial fibrosis is associated with unsuccessful maze operation for valvular atrial fibrillation. European Journal of Cardio-Thoracic Surgery. 2011;40(1):61-9. doi:10.1016/j.ejcts.2010.11.008.; Lip, G. Y., Nieuwlaat, R., Pisters, R., et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest Journal. 2010;137(2):263-72. doi:10.1378/chest.09-1584; Hrynkiewicz-Szymanska A., Dluzniewski M., Platek A.E., Szymanski F.M., et al. Association of the CHADS2 and CHA2DS2-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients. Journal of Thrombosis and Thrombolysis. 2015;40(2): 240-7. doi:10.1007/s11239-014-1154-6.; Saliba W., Gronich N., Barnett-Griness O., et al. Usefulness of CHADS2 and CHA2DS2-VASc scores in the prediction of new-onset atrial fibrillation: a population-based study. The American Journal of Medicine. 2016;129(8):843-9. doi:10.1016/j.amjmed.2016.02.029.; Wessler B.S., Kent D.M. Controversies in cardioembolic stroke. Current Treatment Options in Cardiovascular Medicine. 2015;17(1):358. doi:10.1007/s11936-014-0358-6.; Suissa L., Bertora D., Lachaud S., et al. Score for the targeting of atrial fibrillation (STAF): a new approach to the detection of atrial fibrillation in the secondary prevention of ischemic stroke. Stroke. 2009;40(8):2866-8. doi:10.1161/STROKEAHA.109.552679.; Malik S., Hicks W.J., Schultz L., et al. Development of a scoring system for atrial fibrillation in acute stroke and transient ischemic attack patients: the LADS scoring system. Journal of the Neurological Sciences. 2011;301(1-2):27-30. doi:10.1016/j.jns.2010.11.011.; Fujii S., Shibazaki K., Kimura K., Sakai K., et al. A simple score for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Journal of the Neurological Sciences. 2013;328(1-2):83-6. doi:10.1016/j.jstrokecerebrovasdis.2015.06.019.; Gal P., Parlak E., Demirel F., et al. Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation. Netherlands Heart Journal. 2015;23(9):430-5. doi:10.1007/s12471-015-0709-2.; Saczynski J.S., McManus D., Zhou Z., et al. Trends in atrial fibrillation complicating acute myocardial infarction. The American Journal of Cardiology. 2009;104(2):169-74. doi:10.1016/j.amjcard.2009.03.011.; Beukema R.J., Elvan A., Ottervanger J.P., et al. Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance. Netherlands Heart Journal. 2012;20(4):15-60. doi:10.1007/s12471-012-0242-5.; Gorenek B., Birdane A., Unalir A., et al. Restoring sinus rhythm in patients with atrial fibrillation complicating acute myocardial infarction: Comparison the outcomes of primary angioplasty and thrombolytic therapy. European Journal of Heart Failure. 2000;2(1):32. doi:10.1016/S1388-9842(00)80116-6.; Potpara T.S., Stankovic G.R., Beleslin B.D., et al. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study. Chest. 2012;141(2):339-347. doi:10.1378/chest.11-0340.; Gómez-Outes A., Lagunar-Ruíz J., Terleira-FernándezAI., et al. Causes of death in anticoagulated patients with atrial fibrillation. Journal of the American College of Cardiology. 2016;68(23):2508- 21. doi:10.1016/j.jacc.2016.09.944.; Smit M.D., Moes M.L., Maass A.H., et al. The importance of whether atrial fibrillation or heart failure develops first. European journal of heart failure 2012; 14(9): 1030-1040. doi:10.1093/eurjhf/hfs097.; Worme M.D., Armstrong D.W., Tan M.K., et al. New onset atrial fibrillation in acute coronary syndrome: findings from the GRACE ECG substudy. Canadian Journal of Cardiology. 2016;32(3):s164. doi:10.1016/j.cjca.2016.07.255.; Sinno H., Derakhchan K., Libersan D., et al. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107(14):1930-6. doi:10.1161/01.CIR.0000058743.15215.03.; Alasady M., Abhayaratna W.P., Leong D.P., et al. Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm. 2011;8(7):955-60. doi:10.1016/j.hrthm.2011.02.016.; Thomas R.A., Rubio R., Berne R.M. Comparison of the adenine nucleotide metabolism of dog atrial and ventricular myocardium. Journal of Molecular and Cellular Cardiology. 1975;7(2):115-23. doi:10.1016/0022-2828(75)90013-9; Kabell G., Buchanan L.V., Gibson J.K., et al. Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovascular Research. 1994;28(9):1385-89.; Bertolet B.D., Hill J.A., Kerensky R.A., et al. Myocardial infarction related atrial fibrillation: role of endogenous adenosine. Heart (British Cardiac Society). 1997;78(1):88-90. doi:10.1136/hrt. 78.1.88; Niccoli G., Scalone G., Lerman A., et al. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37(13):1024-33. doi:10.1093/eurheartj/ehv484.; Jumeau C., Rupin A., Chieng-Yane P., et al. Direct Thrombin Inhibitors Prevent Left Atrial Remodeling Associated With Heart Failure in Rats. JACC: Basic to Translational Science. 2016;1(5):328-39. doi:10.1016/j.jacbts.2016.05.002.; Heper G., Korkmaz M.E., Kilic A. Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction? Angiology. 2007;58(6):663-70. doi:10.1177/0003319707308891.; Hassan W., Inam-ur-Rahim S., Hassan M., et al. Coronary artery percutaneous revascularization can be my best way for cardioversion: A case report. Interv Cardiol. 2017;9(3):117-22. doi:10.4172/Interventional-Cardiology.1000565.; Krivonosov D.S., Tarasov N.I., Yurkin E.P., et al. Techniques of pre-admission cardioversion in patients with acute coronary syndrome complicated by a paroxysm atrial fibrillation for prevention of advance of ischemic myocardial damage. Vestnik Aritmologii. 2008;50:25-8. (In Russ.) [Кривоносов Д.С., Тарасов Н.И., Юркин Е.П. и др. Методы догоспитальной кардиоверсии у больных острым коронарным синдромом, осложненным пароксизмом фибрилляции предсердий, в профилактике прогрессирования ишемического повреждения миокарда. Вестник Аритмологии. 2008;50:25-8].; Ibanez B., James S., Agewall S., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-177. doi:10.1093/eurheartj/ehx393; Pesaro A. E., SoeiroA.D. M., Serrano C.V., et al. Effect of β-blockers on the risk of atrial fibrillation with acute myocardial infarction. Clinics. 2010;65(3):265-270. doi:10.1590/S1807- 59322010000300005.; Wi J., Shin D.H., Kim J.S., et al. Transient new-onset atrial fibrillation is associated with poor clinical outcomes in patients with acute myocardial infarction. Circulation Journal. 2016;80(7):1615-23. doi:10.1253/circj.CJ-15-1250.; Kartal E., Ehlbi H., Alp A., et al. Predictors of new - onset atrial fibrillation after ST - segment elevation myocardial infarction in the elderly. Nobel Medicus Journal. 2015;11(3):22-7. doi:10.1016/j.amjcard.2013.07.006.; https://www.rpcardio.com/jour/article/view/1702

Availability: https://www.rpcardio.com/jour/article/view/1702
https://doi.org/10.20996/1819-6446-2018-14-3-451-457

Cardiac multispiral computed tomography: optimization of examination’s protocol for non-invasive cardaic mapping before catheter ablation of atrial fibrrillation ; Мультиспиральная компьютерная томография сердца: оптимизация протокола сканирования при проведении неинвазивного картирования сердца перед катетерной абляцией фибрилляции предсердий

Authors: N. Yu. Kashtanova, I. S. Gruzdev, E. V. Kondrat’ev, Е. A. Artyukhina, М. V. Yashkov, A. Sh. Revishvili, Н. Ю. Каштанова, И. C. Груздев, Е. В. Кондратьев, Е. А. Артюхина, М. В. Яшков, А. Ш. Ревишвили

Source: Medical Visualization; № 3 (2018); 33-48 ; Медицинская визуализация; № 3 (2018); 33-48 ; 2408-9516 ; 1607-0763

Subject Terms: фибрилляция предсердий, left atrium, radiofrequency ablation, noninvasive cardiac mapping, atrial fibrillation, левое предсердие, радиочастотная абляция, неинвазивное картирование сердца

File Description: application/pdf

Relation: https://medvis.vidar.ru/jour/article/view/574/479; Chugh S.S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E.J., Gillum R.F., Kim Y.H., McAnulty J.H. Jr., Zheng Z.J., Forouzanfar M.H., Naghavi M., Mensah G.A., Ezzati M., Murray C.J. World wide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014; 129: 837–847.; Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B., Castella M., Diener H.C., Heidbuchel H., Hendriks J., Hindricks G., Manolis A.S., Oldgren J., Popescu B.A., Schotten U., Van Putte B., Vardas P. ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 2016; 37: 2893–2962. DOI:10.1093/eurheartj/ehw210.; Lloyd-Jones D.M., Wang T.J., Leip E.P., Larson M.G., Levy D., Vasan R.S., D'Agostino R.B., Massaro J.M., Beiser A., Wolf P.A., Benjamin E.J. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004; 110: 1042–1046. DOI:10.1161/01.CIR.0000140263.20897.42.; Krijthe B.P., Kunst A., Benjamin E.J., Lip G.Y., Franco O.H., Hofman A., Witteman J.C., Stricker B.H., Heeringa J. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur. Heart J. 2013; 34: 2746–2751. DOI:10.2147/CLEP.S47385.; Zoni-Berisso M., Lercari F., Carazza T., Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin. Epidemiol. 2014; 6: 213–220. DOI:10.2147/CLEP.S47385.; Kimura K., Minematsu K., Yamaguchi T. Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J. Neurol. Neurosurg. Psychiatry. 2005; 76 (5): 679–683. DOI:10.1136/jnnp.2004.048827.; Tu H.T., Campbell B.C., Christensen S., Desmond P.M., De Silva D.A., Parsons M.W., Churilov L., Lansberg M.G, Mlynash M., Olivot J.-M., Straka M., Bammer R., Albers G.W., Donnan G.A., Davis S.M. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Int. J. Stroke. 2015; 10: 534–540. DOI:10.1111/ijs.12007.; Kuriachan V.P., Sumner G.L., Mitchell L.B. Sudden Cardiac Death. Curr. Probl. Cardiol. 2015; 40 (4): 133–200. DOI:10.1016/j.cpcardiol.2015.01.002.; Calkins H., Kuck K.H., Cappato R., Brugada J., Camm A.J., Chen S.A., Crijns H.J., Damiano R.J. Jr., Davies D.W., DiMarco J., Edgerton J., Ellenbogen K., Ezekowitz M.D., Haines D.E., Haissaguerre M., Hindricks G., Iesaka Y., Jackman W., Jalife J., Jais P., Kalman J., Keane D., Kim Y.H., Kirchhof P., Klein G., Kottkamp H., Kumagai K., Lindsay B.D., Mansour M., Marchlinski F.E., McCarthy P.M., Mont J.L., Morady F., Nademanee K., Nakagawa H., Natale A., Nattel S., Packer D.L., Pappone C., Prystowsky E., Raviele A., Reddy V., Ruskin J.N., Shemin R.J., Tsao H.M., Wilber D.; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and followup, definitions, endpoints and research trial design. Heart Rhythm. 2012; 9 (4): 632–696, e21. DOI:10.1016/j.hrthm.2011.12.016.; Calkins H., Hindricks G., Cappato R. Kim Y.H., Saad E.B., Aguinaga L., Akar J.G., Badhwar V., Brugada J., Camm J., Chen P.S., Chen S.A., Chung M.K., Nielsen J.C., Curtis A.B., Davies D.W., Day J.D., d'Avila A., de Groot NMSN, Di Biase L., Duytschaever M., Edgerton J.R., Ellenbogen K.A., Ellinor P.T., Ernst S., Fenelon G., Gerstenfeld E.P., Haines D.E., Haissaguerre M., Helm R.H., Hylek E., Jackman W.M., Jalife J., Kalman J.M., Kautzner J., Kottkamp H., Kuck K.H., Kumagai K., Lee R., Lewalter T., Lindsay B.D., Macle L., Mansour M., Marchlinski F.E., Michaud G.F., Nakagawa H., Natale A., Nattel S., Okumura K., Packer D., Pokushalov E., Reynolds M.R., Sanders P., Scanavacca M., Schilling R., Tondo C., Tsao H.M., Verma A., Wilber D.J., Yamane T. HRS/EHRA/ ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. Europace. 2018; 20: 157–208. DOI:10.1093/europace/eux275.; Клинические рекомендации “Диагностика и лечение фибрилляции предсердий”; Под. ред. Ревишвили А.Ш., Рзаева Ф.Г., Горева М.В., Нардая Ш.Г. М., 2017; 201 с.; Liddy S., Buckley U., Kok H.K., Loo B., Glover B., Dhillon G.R., Buckley O. Applications of cardiac computed tomography in electrophysiology intervention. Eur. Heart J. Cardiovasc. Imaging. 2018; 19 (3): 253–261. DOI:10.1093/ehjci/jex312.; Гурина В.И., Кондратьев Е.В., Ревишвили А.Ш., Кармазановский Г.Г., Алимурзаева М.З. Оценка анатомии и функции левого предсердия по данным мультиспиральной компьютерной томографии при подготовке к радиочастотной катетерной абляции у пациентов с фибрилляцией предсердий. Медицинская визуализация. 2017; 21 (5): 39–55. DOI:10.24835/1607-0763-2017-5-39-55.; Marrouche N.F., Wilber D., Hindricks G., Jais P., Akoum N., Marchlinski F., KholmovskiE., Burgon N., HuN., Mont L., Deneke Th., Duytschaever M., Neumann Th., Mansour M., Mahnkopf Ch., Herweg B., Daoud E., Wissner E., Bansmann P., Brachmann J. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation. The DECAAF Study. JAMA. 2014; 311 (5): 498–506. DOI:10.1001/jama.2014.3.; Siebermair J., Kholmovski E.G., Marrouche N. Assessment of Left Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging: Methodology and Clinical Implications. JACC Clin. Electrophysiol. 2017; 3 (8): 791–802. DOI:10.1016/j.jacep.2017.07.004.; Ревишвили А.Ш., Калинин В.В., Сопов О.В., Симонян Г.Ю., Ляджина О.С., Фетисова Е.А. Первый опыт хирургического лечения нарушений ритма сердца при помощи неинвазивной системы диагностики поверхностного картирования Амикард-01. Анналы аритмологии. 2011; 1: 47–52.; Ревишвили А.Ш., Артюхина Е.А., Лабазанова А.Л., Калинин В.В., Александрова С.А. Использование диагностического комплекса Амикард для устранения предсердной экстрасистолии из правой верхней легочной вены. Вестник аритмологии. 2011; 66: 59–61.; Revishvili A.S., Wissner E., Lebedev D.S., Lemes C., Deiss S., Metzner A., Kalinin V.V., Sopov O.V., Labartkava E.Z., Kalinin A.V., Chmelevsky M., Stephan V. Zubarev, Maria K. Chaykovskaya, Mikhail G. Tsiklauri, Karl-HeinzKuck. Validation of the mapping accuracy of a novel non-invasive epicardial and endocardial electrophysiology system. Europace. 2015; 17 (8): 1282–1288. DOI:10.1093/europace/euu339.; Артюхина Е.А., Ревишвили А.Ш. Комплексный подход в лечении нарушений ритма с использованием неинвазивного и инвазивного картирования сердца. Высокотехнологическая медицина. 2017; 3: 51–53.; Александрова С.А. Оценка анатомии легочных вен у больных с фибрилляцией предсердий с помощью спиральной компьютерной ангиографии: Автореф. дис. . канд. мед. наук. М., 2004. 23 с.; Cronin P., Kelly A.M., Desjardins B., Patel S., Gross B.H., Kazerooni E.A., Morady F., Oral H., Carlos R.C. Normative analysis of pulmonary vein drainage patterns on multidetector CT with measurements of pulmonary vein ostial diameter and distance to first bifurcation. Acad. Radiol. 2007; 14 (2): 178–188. DOI:10.1016/j.acra.2006.11.004.; Hassani C., Saremi F. Comprehensive Cross-sectional Imaging of the Pulmonary Veins. Radiographics. 2017; 37 (7): 1928–1954. DOI:10.1148/rg.2017170050.; Marom E.M., Herndon J.E., Kim Y.H., McAdams H.P. Variations in pulmonary venous drainage to the left atrium: implications for radiofrequency ablation. Radiology. 2004; 230 (3): 824–829.; Harbi A., Mhish H., Al Shehri H.Z.M., Das K.M. Anatomical variation of pulmonary venous ostium and its relationship with atrial arrhythmia in the Saudi population. J. Saudi Heart Assoc. 2014; 26 (2): 81–85. DOI:10.1016/j.jsha.2013.11.007.; Ревишвили А.Ш., Макаренко В.Н., Александрова С.А. Оценка морфологии легочных вен у пациентов с фибрилляцией предсердий с использованием компьютерной ангиографии. Вестник аритмологии. 2006; 45: 42–47.; Kang K.-W., Pak H.-N., Park J., Park J.G., Uhm J.S., Joung B., Lee M.H., Hwang C. Additional linear ablation from the superior vena cava to right atrial septum after pulmonary vein isolation improves the clinical outcome in patients with paroxysmal atrial fibrillation: prospective randomized study. Europace. 2014; 16: 1738–1745.; Артюхина Е.А., Яшков М.В., Васковский В.А., Ревишвили А.Ш. Радиочастотная аблация аритмогенных зон в правом предсердии у пациентов с фибрилляцией предсердий. Вестник аритмологии. 2018; 91: 44–47.; Leong D.P., Dokainish H. Left atrial volume and function in patients with atrial fibrillation. Curr. Opin Cardiol. 2014; 29 (5): 437–444. DOI:10.1097/HCO.0000000000000088.; Гурина В.И., Кондратьев Е.В., Кармазановский Г.Г., Хацаюк Е.А. МСКТ-волюметрия левого предсердия у пациентов кардиологического профиля. Медицинская визуализация. 2017; 21 (6): 13–18. DOI:10.24835/1607-0763-2017-6-13-18.; Mansour M., Holmvang G., Sosnovik D., Migrino R., Abbara S., Ruskin J., Keane D. Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation. J. Cardiovasc. Electrophysiol. 2004; 15 (4): 387–393. DOI:10.1046/j.1540-8167.2004.03515.x.; Saric M., Armour A.C., Arnaout M.S., Chaudhry F.A., Grimm R.A., Kronzon I., Landeck B.F., Maganti K., Michelena H.I., Tolstrup K. Guidelines for the use of echocardiography in the evaluation of a cardiac source of embolism. J. Am. Soc. Echocardiogr. 2016; 29: 1–42. DOI:10.1016/j.echo.2015.09.011.; Pathan F., Hecht H., Narula J., Marwick T.H. Roles of Transesophageal Echocardiography and Cardiac Computed Tomography for Evaluation of Left Atrial Thrombus and Associated Pathology: Review and Critical Analysis. JACC Cardiovasc. Imaging. 2018; 11 (4): 616– 627. DOI:10.1016/j.jcmg.2017.12.019.; Hilberath J.N., Oakes D.A., Shernan S.K., Bulwer B.E., D’Ambra M.N., Eltzschig H.K. Safety of transesophageal echocardiography. J. Am. Soc. Echocardiogr. 2010; 23: 1115–1127.; Romero J., Husain S.A., Kelesidis I., Sanz J., Medina H.M., Garcia M.J. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a metaanalysis. Circ. Cardiovasc. Imaging. 2013; 6: 185–194. DOI:10.1161/CIRCIMAGING.112.000153.; Bilchick K.C., Mealor A., Gonzalez J., Norton P., Zhuo D., Mason P., Ferguson J.D., Malhotra R., Michael Mangrum J., Darby A.E., DiMarco J., Hagspiel K. Dent J., Kramer C.M., Stukenborg G.J., Salerno M. Effectiveness of integrating delayed computed tomography angiography imaging for left atrial appendage thrombus exclusion into the care of patients undergoing ablation of atrial fibrillation. Heart Rhythm. 2016; 13: 12–19. DOI:10.1016/j.hrthm.2015.09.002.; Chen Y.A., Nguyen E.T., Dennie C., Wald R.M., Crean A.M. Yoo S.-J., Jimenez-Juan L. Computed Tomography and Mag netic Resonance Imaging of the Coronary Sinus: Anatomic Variants and Congenital Anomalies. Insights Imaging. 2014; 5: 547–557. DOI:10.1007/s13244-014-0330-8.; Kaseno K., Hisazaki K., Nakamura K., Ikeda E., Hasegawa K., Aoyama D., Shiomi Y., Ikeda H, Morishita T., Ishida K., Amaya N., Uzui H., Tada H. The impact of the CartoSound® image directly acquired from the left atrium for integration in atrial fibrillation ablation. J. Intervent. Cardiac Electrophysiol. 2018. DOI: org/10.1007/s10840-018-0368-5.; Mosleh W., Sheikh A., DO, Said Z., Abdel-Aal M.A., Gadde S., Shah T., Wilson M.F., Beck H., Kim Ch., Sharma U.C. The Use of Cardiac-CT Alone to Exclude Left Atrial Thrombus Before Atrial Fibrillation Ablation: Efficiency, Safety, and Cost Analysis. Pacing Clin. Electrophysiol. 2018. DOI:10.1111/pace.13353.; https://medvis.vidar.ru/jour/article/view/574

Availability: https://medvis.vidar.ru/jour/article/view/574
https://doi.org/10.24835/1607-0763-2018-3-33-48

LEFT ATRIAL MECHANICAL FUNCTION AND ITS DISORDERS AFTER PULMONARY VEIN ANTRUM ISOLATION ; МЕХАНИЧЕСКАЯ ФУНКЦИЯ ЛЕВОГО ПРЕДСЕРДИЯ И ЕЕ НАРУШЕНИЯ ПОСЛЕ АНТРАЛЬНОЙ ИЗОЛЯЦИИ ЛЕГОЧНЫХ ВЕН

Authors: I. N. Mamchur, T. Y. Chichkova, V. N. Karetnikova, S. E. Mamchur, M. P. Romanova, И. Н. Мамчур, Т. Ю. Чичкова, В. Н. Каретникова, С. Е. Мамчур, М. П. Романова

Source: Complex Issues of Cardiovascular Diseases; Том 7, № 2 (2018); 137-145 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 7, № 2 (2018); 137-145 ; 2587-9537 ; 2306-1278 ; 10.17802/2306-1278-2018-7-2

Subject Terms: механическая функция, cryoablation, radiofrequency ablation, pulmonary vein isolation, left atrium, mechanical function, криоаблация, радиочастотная аблация, изоляция легочных вен, левое предсердие

File Description: application/pdf

Relation: https://www.nii-kpssz.com/jour/article/view/430/338; Диагностика и лечение фибрилляции предсердий / Рекомендации ВНОК и ВНОА. М.; 2011. 84 с.; Кушаковский М.С. Фибрилляция предсердий. СПб; 1999. 175 с.; Brüggenjürgen B., Rossnagel K., Roll S., Andersson F.L., Selim D., Müller-Nordhorn J., Nolte C.H., Jungehülsing G.J., Villringer A., Willich S.N. The impact of atrial fibrillation on the cost of stroke: the Berlin acute stroke study. Value Health.2007; 10: 137-143. doi:10.1111/j.1524 – 4733.2006.00160.x; Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart study. Circulation. 1998; 95: 946 – 952.; Schotten U., Verheule S., Kirchhof P., Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 2011; 91(1): 265-325. doi:10.1152/physrev.00031.2009; Daoud E.G., Bogun F., Goyal R., Harvey M., Man K.C., Strickberger S.A., Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 1996; 94; 1600 – 1606.; Wijffels M.C., Kirchhof C.J., Dorland R., Allessie M.A. Atrial Fibrillation Begets Atrial Fibrillation. A Study in Awake Chronically Instrumented goats. Circulation. 1995; 92: 1954 – 1968. doi:10.1161/01.CIR.92.7.1954; Allessie M.A., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc. Res. 2002; 54: 230-246.; Roy D., Talajic M., Dorian P., Connolly S., Eisenberg M.J.,Thibault B. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N. Engl. J. Med. 2000; 342: 913-920. doi:10.1056/ NEJM200003303421302; Хоменко Е.А. Электрическое выключение критической массы миокарда методом радиочастотной аблации для лечения фибрилляции предсердий. Автореферат дис. …канд. мед. наук. Кемерово; 2013.; Pagel P.S., Kehl F., Gare M., Hettrick D.A., Kersten J.R., Warltier D.C. Mechanical function of the left atrium: new insights based on analysis of pressure-volume relations and Doppler echocardiography. Anesthesiology. 2003; 98: 975 – 994.; Mitchell J.H., Shapiro W. Atrial function and the hemodynamic consequences of atrial fibrillation in man. Am. J. Cardiol. 1969; 23: 556 – 567.; Vizzardi E, D’Aloia A., Rocco E., Lupi L., Rovetta R., Quinzani F., Bontempi l., Curnis A., DeiCas l. How should we measure left atrium size and function? J. Clin. Ultrasound. 2012; 40(3): 155 – 166. doi:10.1002/jcu.21871; Rosca M., Lancellotti P., Popescu B.A., Piérard L.A. Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart. 2011; 97(23): 1982 – 1989.; Рыбакова М.К., Алехин М.Н., Митьков В.В. Практическое руководство по ультразвуковой диагностике. Эхокардиография. М.; 2008. 512 c.; Rahimtoola S.H., Ehsani A., Sinno M.Z., Loeb H.S., Rosen K.M., Gunnar R.M. Importance of left atrial function in patients with myocardial infarction. Circulation. 1983; 67(3): 566 – 571.; Lo H.M., Lin F.Y., Lin J.L., Hsu K.L., Chiang F.T., Tseng C.D., Tseng Y.Z. Impaired cardiac performance relating to delayed left atrial activation after atrial compartment operation for chronic atrial fibrillation. Pacing Clin. Electrophysiol. 1999; 22: 379-381. doi:10.1111/j.1540 – 8159.1999.tb00456.x; Rossi R., Muia N.J., Modena M.G. Relationship between atrial function, left ventricular isovolumic relaxation time, and early filling in dual chamber-paced patients. J. Am. Soc. Echocardiogr. 1997; 10: 300 – 309.; Hettrick D.A., Mittelstadt J.R., Kehl F., Kress T.T., Tessmer J.P., Krolikowski J.G., Kersten J.R., Warltier D.C., Pagel P.S. Effects of atrial pacing lead location and atrial-ventricular delay on atrial and ventricular hemodynamics in dogs. Pacing Clin. Electrophysiol. 2002; 25: 888 – 896.; Sparks P.B., Jayaprakash S., Vohra J.K., Mond H.G., Yapanis A.G., Grigg L.E., Kalman J.M. Left Atrial “Stunning” Following Radiofrequency Catheter Ablation of Chronic Atrial Flutter. J. Am. Coll. Cardiol. 1998; 32: 468-475.; Sun H., Gaspo R., Leblanc N., Nattel S. Cellular Mechanisms of Atrial Contractile Dysfunc-tion Caused by Sustained Atrial Tachycardia. Circulation. 1998; 98: 719-727.; Dogan A., Gedikli O., Ozaydin M., Altinbas A. Mitral annular velocity by Doppler tissue imaging for the evaluation of atrial stunning after cardioversion of atrial fibrillation. Int. J. Cardiovasc. Imaging. 2009; 25(2): 113-120. doi:10.1007/ s10554-008-9360-y; Eren M., Oz D. The mitral late diastolic flow acceleration slope after the restoration of sinus rhythm in acute atrial fibrillation: relationship to atrial function and change over time. Anadolu Kardiyol. Derg. 2010; 10(6): 488-494. doi:10.5152/ akd.2010.163; Zapolski T., Wysokiński A. Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation. Kardiol. Pol. 2005; 63(3): 254-262.; Perea R.J., Tamborero D., Mont L., Brugada J., Caralt T.M., Ortiz-Perez J.T., Berruezo A., Matiello M., Vidal B., Sitges M., Sanchez M. Left atrial contractility is preserved after suc-cessful circumferential pulmonary vein ablation in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 2008; 19(4): 374-379. doi:10.1111/j.1540-8167.2007.01086.x; Anwar A.M., Geleijnse M.L., Soliman O.I., Nemes A., ten Cate F.J. Left atrial Frank-Starling law assessed by real-time, three-dimensional echocardiographic left atrial volume change. Heart. 2007; 93: 1393-1397.; Antonielli E., Pizzuti A., Bassignana A., Tanga A., Baralis G., Rovere E., Di Leo M. Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. Am. J. Cardiol. 1999; 84(9): 1092-1096.; Falcone R.A., Morady F., Armstrong W.F. Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation. Am. J. Cardiol. 1996; 78: 435-439.; Dabek J., Gasior Z., Monastyrska-Cup B., Jakubowski D. Cardioversion and atrial. Pol. Merkur. Lekarski. 2007; 22(129): 224-228.; Mamchur S., Mamchur I., Khomenko E., Kokov A., Bokhan N., Sherbinina D. Mechanical function of left atrium and pulmonary vein sleeves before and after their antrum isolation. Medicina. 2014; 50: 353-359. doi. 10.1016/j.medici.2014.11.008; Мамчур С.Е., Бердников С.В., Мамчур И.Н., Хоменко Е.А., Бохан Н.С. Щербинина Д.А. Зависимость между нагрузкой на левое предсердие и его сократимостью у человека in vivo. Комплексные проблемы сердечно-сосудистых заболеваний. 2014; 1: 47-52.; Kurz M.A., Wead W.B., Roberts A.M. Reflex inotropic responses to distension of left atrium or pulmonary veins. Am. J. Physiol. 1990; 258(1 Pt 2): H121-H126.; Jia B., Li Z.C., Zhang L.L., Dong M.Q., Wang Y.M., Zhou S.S. Pulmonary artery in endotoxemia rat. Effects of atrial natriuretic peptide on relaxation and constriction of aorta and pulmonary artery in endotoxemia rat. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2004; 20(2): 136-140.; Sweeney C.M., Jones J.F., Bund S.J. Adrenoceptor and cholinoceptor modulation of rat pulmonary vein cardiac muscle contractility. Vascul. Pharmacol. 2007; 46(3): 166-170. doi:10.1016/j.vph.2006.09.005; Имнадзе Г.Г., Серов Р.А., Ревишвили А.Ш. Морфология легочных вен и их мышечных муфт, роль в возникновении фибрилляции предсердий. Вестник аритмологии. 2003; 34: 32-37.; Мамчур С.Е, Мамчур И.Н., Хоменко Е.А., Бохан Н.С. Щербинина Д.А., Горшкова Т.В., Горбунова Е.В. Взаимосвязь показателей качества жизни и механической функции левого предсердия у пациентов после успешной радиочастотной изоляции легочных вен по поводу идиопатической пароксизмальной формы фибрилляции предсердий. Сибирский медицинский журнал. 2015; 1(30): 55-59.; Gibson D.N., Di Biase L., Mohanty P., Patel J.D., Bai R., Sanchez J., Burkhardt J.D., Heywood J.T., Johnson A.D., Rubenson D.S., Horton R., Gallinghouse G.J., Beheiry S., Curtis G.P., Cohen D.N., Lee M.Y., Smith M.R., Gopinath D., Lewis W.R., Natale A. Stiff left atrial syndrome after catheter ablationfor atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm. 2011; 8: 1364-1371. doi:10.1016/j. hrthm.2011.02.026; Calkins H., Kuck K.H., Cappato R., Brugada J., Camm A.J., Chen S.A., Crijns H.J., Damiano R. J., Davies D.W., DiMarco J., Edgerton J., Ellenbogen K., Ezekowitz M.D., Haines D.E., Haissaguerre M., Hindricks G., Iesaka Y., Jackman W., Jalife J., Jais P., Kalman J., Keane D., Kim Y.H., Kirchhof P., Klein G., Kottkamp H., Kumagai K., Lindsay B.D., Mansour M., Marchlinski F.E., McCarthy P.M., Mont J.L., Morady F., Nademanee K., Nakagawa H., Natale A., Nattel S., Packer D.L., Pappone C., Prystowsky E., Raviele A., Reddy V., Ruskin J.N., Shemin R.J., Tsao H.M., Wilber D. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012; 14(4): 528-606. doi:10.1007/s10840-012-9672-7; Kuck K.H., Fürnkranz A., Chun K.R., Metzner A., Ouyang F., Schlüter M., Elvan A., Lim H.W., Kueffer F.J., Arentz T., Albenque J.P., Tondo C., Kühne M., Sticherling C., Brugada J., FIRE AND ICE Investigators. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur. Heart J. 2016; 37(38): 2858-2865. doi:10.1093/eurheartj/ehw285; Khairy P., Chauvet P., Lehmann J., Lambert J., Macle L., Tanguay J.F., Sirois M.G., Santo-ianni D., Dubuc M. Lower Incidence of Thrombus Formation With Cryoenergy Versus Radiofrequency Catheter Ablation. Circulation. 2003; 107(15): 45-50. doi:10.1161/01.cir.0000058706.82623.a1; Мамчур И.Н., Чичкова Т.Ю., Мамчур С.Е., Бохан Н.С., Романова М.П., Хоменко Е.А. Сравнительный анализ нарушения механической функции левого предсердия после процедуры антральной изоляции легочных вен методом радиочастотной и криобаллонной аблации. Российский кардиологический журнал. 2017; 8: 24-30.; Мамчур С.Е., Романова М.П., Горбунова Е.В., Бохан Н.С., Чичкова Т.Ю. Upstream-терапия телмисартаном и амлодипином после антральной изоляции легочных вен при фибрилляции предсердий. Вестник аритмологии. 2016; 86: 7-14.

Availability: https://www.nii-kpssz.com/jour/article/view/430
https://doi.org/10.17802/2306-1278-2018-7-2-137-145

PROGNOSTIC VALUE OF LEFT ATRIAL FUNCTIONAL PARAMETERS IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE AND PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION

Authors: K. G. Adamyan, L. R. Tumasyan, A. L. Chilingaryan

Source: Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 40-47 (2013)

Subject Terms: pulmonary vein, nt-probnp, diastolic function, ivabradine, хроническая сердечная недостаточность, chronic heart failure, left atrium, 3. Good health, 03 medical and health sciences, легочные вены, 0302 clinical medicine, мозговой натрийуретический пептид, диастолическая функция, RC666-701, прогноз, левое предсердие, high sensitivity c reactive protein, Diseases of the circulatory (Cardiovascular) system, nt-промозговой на-трийуретический пептид высокочувствительный с-реактивный белок, prognosis, bnp

Access URL: https://www.heartj.asia/jour/article/download/5538/5547
https://doaj.org/article/fdbc700be3644f54b7bb488917247ab1

БИОМЕХАНИКА ЛЕВОГО ЖЕЛУДОЧКА И ЛЕВОГО ПРЕДСЕРДИЯ У БОЛЬНЫХ НЕДОСТАТОЧНОСТЬЮ МИТРАЛЬНОГО КЛАПАНА

Subject Terms: mitral insufficiency, векторный анализ, left ventricle, левый желудочек, левое предсердие, myocardium, deformation, миокард, speckle tracking imaging, митральная недостаточность, деформация, 3. Good health, left atrium

The relationship of quality of life and the mechanical function of the left atrium in patients after successful radiofrequency isolation of the pulmonary veins for idiopathic paroxysmal atrial fibrillation ; Взаимосвязь показателей качества жизни и механической функции левого предсердия у пациентов после успешной радиочастотной изоляции легочных вен по поводу идиопатической пароксизмальной формы фибрилляции предсердий

Authors: D. A. Sherbinina, S. E. Mamchur, I. N. Mamchur, E. A. Khomenko, N. S. Bokhan, T. V. Gorshkova, E. V. Gorbunova, Диана Александровна Щербинина, Сергей Евгеньевич Мамчур, Ирина Николаевна Мамчур, Егор Александрович Хоменко, Никита Сергеевич Бохан, Татьяна Владимировна Горшкова, Елена Владимировна Горбунова

Source: Siberian Journal of Clinical and Experimental Medicine; Том 30, № 1 (2015); 55-59 ; Сибирский журнал клинической и экспериментальной медицины; Том 30, № 1 (2015); 55-59 ; 2713-265X ; 2713-2927 ; 10.29001/2073-8552-2015-30-1

Subject Terms: mechanical function, изоляция легочных вен, левое предсердие, механическая функция, quality of life, pulmonary vein isolation, left atrium

File Description: application/pdf

Relation: https://www.sibjcem.ru/jour/article/view/143/144; Feinberg W.M., Blackshear J.L., Laupacis A. et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications // Arch. Intern. Med. - 1995. -Vol. 155. - P. 469-473.; Wang T.J., Larson M.G., Levy D. et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study // Circulation. -2003. - Vol. 107. - P. 2920-2925.; Benjamin E.J., Wolf P.A., D’Agostino R.B. et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart study // Circulation. - 1998. - Vol. 98. - P. 946-952.; Stewart S., Hart C.L., Hole D.J. et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study // Am. J. Med. - 2002. -Vol. 113. - P. 359-364.; Gallegoa A.M., Diaz-Infantea E., Garcia-Bolaoa E. Spanish Catheter Ablation Registry. 8th Official report of the Spanish Society of Cardiology Working Group on electrophysiology and arrhythmias (2008) // Rev. Esp. Cardiol. - 2009. - Vol. 62(11). - P. 1276-1285.; Earley M., Abrams D., Staniforth A. et al. Catheter ablation of permanent atrial fibrillation: medium term results // Heart. - 2006. - Vol. 92. - P. 233-238.; Мамчур С.Е., Мамчур И.Н., Хоменко Е.А. и др. Механическая функция левого предсердия и легочных вен до и после их антральной изоляции // Вестник аритмологии. - 2013. -№ 71. - С. 5-11.; Gibson D.N., Di Biase L., Mohanty P. et al. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors // Heart Rhythm. - 2011. - Vol. 8. - P. 1364-1371.; Henein M. Left atrial function in health and disease. - Umea: Department of Public Health and Clinical Medicine, 2012. -118 p.; Pagel P.S., Kehl F., Gare M. et al. Mechanical function of the left atrium // Anesthesiology. - 2003. - Vol. 98. - P. 975-994.; Calkins H., Kuck K.H., Cappato R. et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design // Europace. - 2012. - Vol. 14. - P. 528-606.; https://www.sibjcem.ru/jour/article/view/143

Availability: https://www.sibjcem.ru/jour/article/view/143
https://doi.org/10.29001/2073-8552-2015-30-1-55-59